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ABSTRACT

FROM ENGINEERING OF TUMOR SHRINKING DDS TO ENGINEERING THE
NUCLEUS FOR TUMOR GROWTH
Takamasa Harada
Prof. Dennis E. Discher
Key questions in this study are how to shrink tumors in vivo and what physical property of cancer
cell determines tumor invasiveness. Delivery of drug molecules to distant tumor tissue in the body
is the highest challenge in any types of cancer therapies, and this goal was approached from two
aspects in the first half of the study, namely using worm-like shaped drug delivery vehicle or
Filomicelle and adding protein CD47 to the vehicle surface, which can send a stop signal to
macrophage phagocytosing a foreign material. Drug-loaded Filomicelles applied for brain tumor
treatment in combination with radiation therapy to obtain the access inside brain tissue by
disrupting blood brain barrier. CD47-attached particle was tested for accumulation in tumor
tissue, followed by subcutaneous tumor shrinkage study. Second half of the study focuses on cell
nuclear physics in the context of cell migration and tumor progression as a physiological example
where cell migration plays an essential role for progression. Nuclear stiffness was controlled by
changing the expression of Lamin-A,C, a protein forming mesh struture underneath inner nuclear
membrane to give a physical strength the nucleus. Relative expression of Lamin-A,C to its
isoform Lamin-B nicely predicts behavior of nuclear shape after stress application and importantly
cell migration sensitivity against Lamin-A,C change through physically constraining environment.
This observation leads to quite simple viscoelastic model in which Lamin-A,C and –B are
responsible for nuclear viscosity and elasticity, respectively.
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Chapter 1: Introduction

1-1. Tumor Shrinkage with Flexible Filomicelles
Delivering therapeutic agents specifically to tumor tissue is the ultimate goal in targeted
therapeutics for cancer (Allen and Cullis, 2004). One important approach to this goal is to invent
a nano-sized delivery carrier that has capabilities to load a cargo stably and to circulate in blood
stream for extended period of time without losing the cargo until it reaches the target site. One of
the most common types of nano-sized carrier studied is a self-assembled particle composed of
amphiphilic co-polymers (Discher and Eisenberg, 2002; Kataoka et al., 2001). Amphiphilic
copolymer is generally composed of hydrophilic (in most cases poly(ethylene glycol) or PEG)
and hydrophobic segments, and can self-assemble in aqueous condition via hydrophobic
interaction. Hydrophobic core of the self-assembled particle serves as a reservoir for various
kinds of therapeutic reagents such as hydrophobic anti-cancer drug paclitaxel. Various kinds of
chemical modifications are possible to improve the capabilities of delivery system, from
conjugation of drug molecules to polymers via stimulus sensitive linkers for stable loading and
controlled release of cargo (Ganta et al., 2008; Gupta et al., 2002), to modification of carrier
surface with ligand molecules to increase specificity to target cells (Torchilin). Chemical
modifications for the building polymer have been extensively studied, but recently a lot of
attention has been paid to the shape (i.e. non-spherical shape) and physical properties for delivery
carriers.
Sub-micron particles with non-spherical shape can be prepared by various methods such
as physically deforming spherical particle to non-spherical shape (Champion and Mitragotri,
1

2006) or top-down lithography (Gratton et al., 2008). Previous works in Discher lab tried to
prepare non-spherical particle by careful tuning of the molecular weight ratio of
hydrophobic/hydrophilic segments in amphiphilic diblock copolymers so that the polymers can
self-assemble into mainly three morphologies: conventional spherical micelles, spherical polymer
vesicles or polymersomes and importantly cylindrical worm-like micelles or Filomicelles
(Rajagopal et al.). Although depending on the chemical properties of comprising polymer’s
hydrophobic segment, it is possible to prepare Filomicelles with remarkable flexibility both in
static condition and under flow. The flexibility and resulting vigorous movement of Filomicelles
allow them to interact with phagocytic immune cells, which are responsible for the clearance of
injected foreign material from blood circulation (discussed more in 1-2), for only a short time.
Flexible Filomicelles showed surprisingly longer blood circulation time in comparison with
spherical polymersome that also has PEG layer on surface (Geng et al., 2007).
Basic mechanism for the accumulation of injected particles in tumor tissue is diffusion
through leaky walls of tumor vasculature and lack of clearance from the tumor tissue due to
deficient lymphatic drainage, which are collectively called enhanced permeability and retention
(EPR) effect (Maeda et al., 2000). Previous study showed that Filomicelle, which has 10~20 nm
cross-section diameter, could permeate into porous hydrogel (Kim et al., 2005), while 100 nm
spherical vesicle could not. Combined with the extended blood circulation time, it is reasonable to
expect Filomicelles to show higher probability of eventually reaching the tumor tissue and
interact with target cancer cells. Indeed, a model study showed that flexible 8 m Filomicelles
could successfully suppressed the growth of subtaneous tumor, almost 2-fold higher efficiency
than short 1 m cylindrical micelle loaded with the same amount of anti-cancer drug paclitaxel.
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1-2. Enhanced Circulation via Avoidance of Immune Cell Clearance
Long circulation of drug delivery carriers is beneficial in increasing the probability of the
particles to go throughout the body, reaching organs that could have a tumor highly difficult to be
removed by surgery. Biggest barrier for achieving long circulation is recognition and following
clearance by immune cells such as macrophages in spleen and liver . PEG brush on the outer
surface of many of self-assembled nano-particles can physically repel the attachment of various
proteins in blood called opsonins, which can trigger the recognition and uptake by immune cells.
However, most of the PEG-coated particles eventually get attached with those opsonin molecules
(‘opsonized,’ see table 3-1) and cleared within time scale of hours to days from circulation. To
maximize the therapeutic effect of drug-loaded delivery particles in a single injection, it is
beneficial to add capabilities to (i) avoid the attachment of opsonin molecules by having PEG
brush on surface, and (ii) to have a way to send a signal to immune cells to stop the process of
uptake or phagocytosis.
Previous study from Dishcer lab showed that macrophages do not phagocytosed particles
in contact when nano to micron sized particles have a protein called CD47 on the surface (Tsai
and Discher, 2008). CD47 is known to interact with receptor protein on macrophages called
SIRP, sending a signal to stop the myosin II-dependent contraction and the start membrane
protrusion, which is an initial step for phagocytosis (Oldenborg et al., 2000). Few studies have
aimed for achieving drug delivery system that can actively avoid the clearance by immune cells
rather than only having PEG to prevent the opsonization. Therefore it is essential to investigate if
CD47 can serve as a clearance-avoiding moiety on the surface of synthetic nano-particle in blood
circulation as it did on red blood cell in mice.
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1-3. Cell Migration and Cancer Progression
Cancer prognosis, or precise estimation of how quickly the disease progresses, is an essential part
of cancer therapy. Motility of cancer cells can be an important indicator of tumor propagation,
considering that in adult animals it underlies a wide range of critical processes, including tumor
dissemination and stem cell homing. In the early stages of the “invasion-metastasis cascade”
(Weinberg, 2007), cells in the tumor periphery crawl through surrounding extracellular matrix
(ECM) and acquire space to divide, with some cells entering blood capillaries in metastasis to
distant tissues. Successful migration requires cells to survive large distortions as they squeeze
their way through ECM or across a basement membrane, and the largest single organelle in every
cell is typically the nucleus, which tends to be stiff in many cell types (Lammerding et al., 2006;
Pajerowski et al., 2007).

In light of cytoskeletal-generated stresses in cell crawling, we

hypothesized key roles for nuclear mechanics, which is largely determined by protein called
Lamin-A,C as explained in detail in the next section, in 3D migration and cell survival.
Gradually accepted is the idea that cancer, of particular interest in this study, shows
notable difference in Lamin-A,C profiles from healthy cells, depending on the disease type. The
altered expression of Lamin-A,C in neoplastic cells is expected to be a promising biological
marker for early diagnosis as well as key protein for disease progression. Mounting evidence
suggests that different types of cancer cells have altered Lamin A/C expression levels, often
leading to higher malignancy (Foster et al., 2010; Kaufmann et al., 1991). Recent reports have
shown that stage II and III colon cancer tumors with low Lamin-A,C expression led to higher
rates of disease recurrence (Belt et al., 2011). Contrarily, Lamin-A,C expression in squamous cell
carcinoma, basal cell carcinoma and colorectal cancer positively correlated with its malignancy
(Foster et al., 2010; Tilli et al., 2003). Thus current evidence for the involvement of Lamin-A,C in
4

cancer leads to contradicting conclusions, probably due to the complexity of interactions that
involve Lamins.

1-4. Nuclear Lamin Overview
Nuclear Lamina is a protein meshwork residing right underneath the inner nuclear membrane.
Main components of the meshwork are nuclear Lamins, which are grouped into two isoforms: Atype and B-type Lamins. Lamins are categorized as a type V intermediate filament (Shin et al.)
protein, which is composed of -helical coiled-coil rod domain flanked by head and tail domains
like all the other IF proteins. The N-terminal globular head domain has a highly charged non-helical structure, whereas also highly charged tail domain at C-terminal is containing highly
conserved 105 amino acid region with immunoglobulin (Ig)-fold structure as well as nuclear
localization signal (Ben-Harush et al., 2009; Broers et al., 2006; Zastrow et al., 2004). Lamin
molecules form a dimer by making coiled-coil structure in their rod domain, which serves as a
fundamental building block for further polymerization into filamentous head-to-tail assembly.
Two dimers associate together through electrostatic interaction in anti-parallel manner. This
tetramer further polymerizes into a strand, eight of which eventually stack into a filament of 10
nm in diameter (figure 1-1).
A-type Lamins (Lamin-A, -C, -AΔ10 and -C2) are found in most of differentiated cells
with involvement in chromatin organization, transcription, translation, cell differentiation and
many other functions (Andres and Gonzalez, 2009; Zastrow et al., 2004). Alternative splicing of
mRNA of a single gene LMNA produces all A-type Lamin proteins (spliceoforms), among which
strong focus is placed on Lamin-A,C in this study. In addition to involvement in the various
biological roles, Lamin-A,C makes remarkable contribution to the physical properties of cell
5

nucleus in expression depending manners (Pajerowski et al., 2007). The work furthermore
measured increase of nuclear stiffness in the time course of differentiation in pluripotent human
embryonic stem cells, which have initially undetectable Lamin-A,C level and increase the
expression along differentiation pathway. Interestingly, not only reflecting the differentiation
status, but Lamin-A,C expression (Swift. et. al.) and nuclear stiffness of various cells with distinct
origins seems indicative of the tissue stiffness in which those cells reside. Underlining mechanism
for strong correlation between nuclear and tissue stiffness could be the strong connection from
extracellular environment to cell nucleus. Lamin-A,C is connected to the cytoskeleton (actin
filaments, microtubules and cytoskeletal IFs) thorough the LINC (linker of nucleus and
cytoskeleton) complex (Mejat and Misteli), thus making it a transducer of mechanical stimuli
from the environment to the nucleus (Chancellor et al.). B-type Lamins, Lamin-B1 and -B2, are
transcribed by separate genes, LMNB1 and LMNB2, respectively. Lamin-Bs are expressed in all
types of cells in any developmental stage, and known to be involved in cell viability and tissue
development but showing less obvious contribution to nuclear rigidity (Lammerding et al., 2006).
In addition to the significant influence of expression levels of Lamins on early
development and maturation, particularly Lamin-A,C functions show surprising sensitivity
against mutations. So far, over 200 different mutations in LMNA gene are reported, and the
diseases derived from LMNA mutations are collectively called Laminopathies. Among
Laminopathies with diverse disease phenotypes, Hutchinson-Gilford progeria syndrome (HGPS),
which essentially causes premature aging, is especially intriguing. Lamin-A,C of HGPS patients
possesses C-terminal farnesyl group, which is cleaved in the course of post-translational
modifications, causing altered interactions between Lamin-A,C proteins and inner nuclear
membrane. Due to this altered interaction, fibroblasts from HGPS patients showed notable
phenotype of irregular nuclear morphology (Scaffidi and Misteli, 2006). Observation of HGPS
6

cell nuclei also supports the idea that Lamin-A,C is an important factor for nuclear morphology,
and possibly the mechanics. Mutation in LMNBs is yet to be connected to any disease possibly
due to the involvement of Lamin-Bs in cell viability.

1-5. Nuclear Mechanics
Nucleus experiences significant deformation while the cells is migrating through physically
constraining environment (Friedl et al.). Once the cell is released from the constraints, the nuclear
shape could go back to the relaxed state (ellipsoidal shape as usually observed in static culture)
but with the rate dominated by the physical nature of the nucleus. In polymer physics, the all
materials are categorized as viscoelastic. When a stress is applied to an ideal viscous material, the
shape of the material slowly changes and the energy of the applied stress dissipates as the
material perpetually deforms. In contrast, an ideal elastic material instantaneously responds to the
stress applied. The energy from the stress is stored in the material, and shape will go back to the
original one once the force application is ceased. When stress is applied to viscoelastic polymer
material, part of the energy is stored but remaining part is consumed for terminal deformation.
How quickly a polymer material responds to force or how quickly the material changes its shape
back to the normal state after releasing stress depend on the balance of the extent of viscosity and
elasticity.
To migrate through the transwell filter, cells require time scale of ~hours (figure 2-2C)
with significant nuclear deformation in the circular column-shaped transwell pore. Terminal
observation after 24 hours looks at the shape of nucleus that have had time scale of ~hours for
turning back the shape to relaxed state in stress-free condition. Therefore, comparison of nuclear
shape of cells on top (before migration) and bottom (after migration) sides of the transwell filter
7

should give the insight on how viscous/elastic the nucleus of particular cell line is. That is, cells
with more viscous nucleus should greater difference in nuclear shape between two sides of the
transwell membrane. The extent of nuclear shape change after migration is correlated first to the
Lamin-A,C:B ratio to see if Lamin isoform dominance affects the viscoelastic nature of the cell
nucleus, particularly under stress in long time scale (~hours).
For shorter time scale analysis of nuclear viscoelasticity, partial deformation induced by
micropipette aspiration is suitable to measure the response time of nucleus against aspirating
pressure. In micropipette aspiration experiments, nucleus of cytoskeleton-disrupted cells is put
under constant negative pressure in glass needle. Under the pressure, the nuclear membrane
extension into the glass pipette is monitored to evaluate the deformability of nucleus. As shown in
previous work (Dahl et al., 2005; Pajerowski et al., 2007), physical property of nucleus is largely
determined by nuclear Lamina, which is a meshwork structure composed of polymerized filament
of Lamin molecules. As regular viscoelastic polymeric material, cell nucleus shows creep
behavior in pipette under pressure, and creep compliance of the nuclear membrane under negative
pressure can be calculated by
J(t) = (4/3)  (L/D) (1/P)
, where constant  is 2.1 (Theret et al., 1988), L is a length of nuclear membrane extension inside
micropipette, D is an internal diameter of the pipette and P is an applied aspiration pressure.
From nuclear creep compliance, one can calculate elastic stiffness of the nucleus:
E(t) = (sin()/) (1/J(t))
, where  is a power obtained by fitting nuclear compliance data to the power low.

8

1-6. Thesis Overview
One of the two main goals of this study is to validate the advantage of long circulating capability
of the drug delivery carrier in two aspects: shape of the particle and ability to escape the immune
cell clearance. In chapter 1, long circulating Filomicells with loaded drug was applied for the
treatment of brain cancer cells. After basic characterization, the TAX-loaded Filomicelles were
tested for tumor shrinkage in two distinct system: model subcutaneous tumors and orthotopic
intracranial tumors. To overcome the strict physical barrier in barin vasculature wall, radiation
therapy was combined to maximize the therapeutic effects of drug loaded Filomicelles. In the
following chapter 2, the effect of CD47 attached on model particle was studied in the context of
tumor accumulation and shrinkage. TAX-loaded particles with CD47 were tested for their
cytotoxicity in vitro and for tumor shrinkage in vivo after visualization of enhanced tumor
accumulation using hydrophobic near infrared dye loaded on those particles.
The second main goal of this thesis is to expand the understanding of Lamin-A/C roles in
cell migration. First, the dependence of cell migration efficiency is explored in vitro using a
technique called transwell migration assay, where cells are induced chemotactic migration
through pores of certain sizes, with Lamin-A,C expression modified by genetic methods (RNA
interference or overexpression). Three cell lines with distinct natures including origin, migration
capacity and Lamin expression profile are tested to achieve broad understanding of the influence
of Lamin-A/C on cell migration. Based on this observation, in-depth biophysical analyses of
nuclei in the three cell lines are tried by applying basic viscoelastic model of polymer physics.
Then, another aspect of nuclear Lamina in the context of cell migration was explored: the
physical protection against migration-associated mechanical stress. In this part, one mechanism
for resisting stress during cell migration process is revealed with the help of mass spectrometry.
9

Lastly the effect of Lamin-A,C knockdown in tumor propagation is explored using tumor
xenograft, as a model study of in vivo function of Lamin-A,C.

10

Figure 1-1. Overview of the thesis The main aims of this thesis is to obtain new insight into (i)
how tumors can be effectively killed using synthetic drug delivery carrier and (ii) how the
physical properties of individual cancer cells affect overall growth of tumor. In chapter 2, longcirculating drug delivery vehicle with unique morphology, Filomicelle, was tested for the use in
treatment against brain tumor in conjunction with radiation. For the achievement of even longer
circulation, the advantage of attaching CD47 on nano-particle was validated using various
imaging techniques in chapter 3. Chapter 4 reveals important insight on how cell physics,
particularly focusing on cell nuclear stiffness and flexibility, affects the cancer cell migration,
which is important in many processes involved in cancer progression.
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Chapter 2: Filomicells for Tumor Shrinkage
Portion of this work contributes to Baumann et. al., submitted.

In this chapter, anti-cancer drug-loaded polymeric micelle with worm-like shape, Filomicelle is
tested for its therapeutic efficacy against glioblastoma multiforme, a type of brain tumor cells,
both in vitro and in vivo. The objective of this chapter is to show the importance of long blood
circulation for drug delivery carriers to achieve substantial tumor shrinkage. Orthotiopic brain
tumors represent one of the hardest tumor types to treat due to the physical blocking in their
vascular walls. These tumors were treated with drug-loaded Filomicelles in combination with
radiation therapy, which is known to disrupt the brain endothelium, to test if the capacity of long
blood circulation is sufficient to treat brain tumors once the particles acquire the access to the
tissue.

2-1. Introduction
Although showing strong cytotoxicity against cancer cells, many approved drugs have a
problem in reaching target disease site such as solid tumor tissue, which results in still high
mortality of cancer in general. Achieving delivery of anti-cancer drug molecules to target site
with high specificity is a key to successful cancer therapy. Solid tumors often have leaky vascular
systems with holes of 200-300 nm and have impaired blood flow compared to the circulation
through normal tissue. Structural characteristics of tumor vascularity such as increased tortuosity,
irregular shape and dilation of blood vessels coupled with endothelial fenestrations result in
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leakage of blood plasma macromolecules and injected drugs into tumor tissue through molecular
diffusion. The phenomenon of enhanced permeation of macromolecules, followed by retention
and concentration of these macromolecules within tumor tissue due to deficient lymphatic
drainage, is a referred to as the enhanced permeability and retention (EPR) effect (Iyer et al.,
2006; Luo and Prestwich, 2002). The EPR effect is the basis, for example, of preferential uptake
of gadolinium contrast agents into tumors, compared to normal brain tissue, as observed by
magnetic resonance imaging (MRI). The anatomical and physiological factors promoting the EPR
effect that leads to increased intravasation of circulating molecules however are not uniformly
distributed throughout tumors (Ewing et al., 2006; Muldoon et al., 2007). The EPR effect is often
maximal at core regions within a tumor, regions frequently characterized by necrosis, while the
EPR effect is diminished at the peripheral zones of a tumor. These peripheral areas may contain
many viable cancer cells.
Over 20,000 Americans are diagnosed annually with glioblastoma multiforme (GBM).
Standard treatment usually consists of surgery, radiation therapy (RT), and temozolomide
chemotherapy, but median survival is only about 14.6 months (Stupp et al., 2005). Given these
unsatisfactory results, new therapeutic approaches are clearly needed. Although other
chemotherapeutic drugs such as paclitaxel are effective against GBM cells in vitro, they are
clinically ineffective against GBM (Langer et al., 2001). The limited efficacy of such drugs has
been attributed to an inability to achieve therapeutic concentrations of these drugs in the tumor
due to the presence of the blood-brain barrier (BBB) – specifically the BBB within the tumor.
Modulation of both drug delivery and the integrity of the BBB thus represent intriguing strategies
for enhancing treatment efficacy.
A novel approach to maximize EPR-driven concentration of chemotherapeutic agents
within tumors is utilization of drug-loaded nanocarriers (DLNs) that stably incorporate drug
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molecules and thereby minimize both excretion and generic permeation in healthy tissues.
Filomicelles are one type of recently developed DLN, composed of amphiphilic diblock
copolymer that can self-assemble through hydrophobic interaction into filamentous particle, with
capability incorporate hydrophobic molecules including widely variety of anti-cancer drugs in its
hydrophobic core. Filomicelles avoid rapid clearance by the mononuclear phagocytic system
(MPS) of the liver and spleen through outer poly(ethylene glycol) (PEG) layer physically
repelling the attachment of opsonin molecules, resulting in increased serum half-life and maximal
drug delivery to subcutaneous tumor xenografts with improved anti-tumor efficacy (Geng et al.,
2007). Flexibility of the filaments was also shown to be important to circulate through blood
stream crowded with blood cells, and the crystalline rigidity of past polymer assemblies is
suppressed here with novel hydrophilic-linked-hydrophobic block copolymers of poly(ethylene
oxide)-block-poly(ε-caprolactone-random-D,L-lactide) (OCLA), that randomize the packing in
the hydrophobic, polyester core. Filomicelles have been shown to even flow through the brain
vasculature, but like other DLN they do not permeate the BBB (Christian et al., 2009). Therefore
disruption of the BBB might enhance the effectiveness of DLNs for treating intracranial tumors.
Conventional approaches for disrupting the BBB transiently before delivery of chemotherapy,
such as efflux transporter inhibitors, bradykinins, and intra-arterial infusions of osmotic
disruption agents (e.g. mannitol) lack specificity against tumor-associated vasculature, which can
potentially result in serious side effects (Doolittle et al., 2000; Guillaume et al.; Jahnke et al.,
2006; Neuwelt et al., 2008). In contrast, targeted radiation therapy (RT) offers an ideal solution
for focally disrupting the tumor BBB and avoiding normal brain (Cao et al., 2005; Deeken and
Loscher, 2007; Lemasson et al.).
In this chapter, filomicelles are studied for the delivery of model drug paclitaxel (TAX),
which is a widely used anti-cancer agent against many different types of cancer including breast,
18

ovarian and lung cancer (Rowinsky and Donehower, 1995). Basic characterization of drug
loading and release is followed by in vitro toxicity assay and in vivo tumor shrinkages studies.
Therapeutic efficacy of TAX-loaded Filomicelle was tested against two tumors models:
subcutaneous and intracranial tumors. Combination therapy of TAX-Filomicelle and Radiation
was tested against intracranial tumors, which requires the penetration of drug-loaded particles
through BBB in brain tissue vascular walls.

2-2. Results and Discussion
2-2-1. Paclitaxel-loaded Filomicelles Effectively Kills Glioblastoma
To efficiently deliver therapeutic agents to target sites, DLNs need to avoid interaction with MPS
and physical trap in tissues (Geng et al., 2007). Our Filomicelles are composed of novel diblock
copolymer OCLA, forming PEGylated outer layer for the particle to avoid opsonization or
binding of certain groups of proteins, which eventually causes immune recognitions. In addition
to the “stealth” property by PEG, it also essential for Filomicelles to retain flexibility to crawl
through crowd of circulating cells in blood vasculature. The hydrophobic core of the OCLA
polymer is composed of random copolymer of ε-caprolactone and D,L-lactide, both of which are
FDA-approved materials, to inhibit the crystal structure formation of Poly(caprolactone) that
happened with our previous Filomicelle studies with PEG-b-Poly(ε-caprolactone).
OCLA polymers successfully form long filomicelles with average length of 12.5 m
(Fig. 2-1A and B), and can be loaded with widely used anti-cancer drug paclitaxel (TAX), which
binds to microtubule to cause failure in mitosis and eventually growth arrest and apoptosis. TAX
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molecules loaded in the core of Filomicelles go through two distinct phases of release from the
carrier, showing burst release over fist 1 hour followed by sustained release.
Paclitaxel-loaded filomicelles were tested for in vitro cytotoxicity against glioblastoma
cells, as well as polymersomes with different concentration of salts in their aqueous lumen,
mixture of short cylinders/spherical micelles (OCL3) and free drug control (Fig. 2-2A). Increased
salt concentration was loaded in polymersome lumen to see if release of the excess salts inside
endosome can cause the rupture of the lipid vesicle membrane due to osmotic pressure. 48-hour
treatment with TAX-loaded formulations resulted in very similar IC50 values for all the tested
particles, giving < 0.1 g/mL for two glioblastoma lines U251 and SF767. For T98G cell line
(Fig. 2-2B), OCLA2-12 derived filomicelles showed the highest therapeutic effect, even > 4-fold
higher than free drug control. Interestingly, polymersomes from OCLA2-7.5 containing 2-fold
higher salt concentration than physiological condition showed increased cytotoxicity effect
against 2 (out of 3) tested cell lines.

2-2-2. Paclitaxel-loaded Filomicelles Effectively Shrank Glioblastoma-derived Subcutaneous
Tumors, but Combination Therapy with Radiation is required for Intracranial Tumor
Shrinkage
Since U251 cells showed high sensitivity against TAX-treatment and stable tumor growth in nude
mice, subcutaneous tumor was established with U251 cells to evaluate the in vivo therapeutic
efficacy of TAX-loaded Filomicelles. Treatment with TAX-loaded Filomicelles successfully
suppressed the subcutaneous tumor growth for over 4 weeks (Fig. 2-3).
As aforementioned, crossing through BBB is an essential step for drug delivery into a
brain tumor. Although flexible Filomicelles showed blood circulation long enough to reach brain
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vasculature, they fail to intravasate into surrounding tissues due to BBB’s tight regulation of
material transport as previously shown with near-infrared dye-loaded Filomicelles localized in the
blood vessel 24 hours after administration. Considering the previous work showing disruption of
BBB including vasculature in brain tumor tissue by radiation therapy (Cao et al., 2005), we
hypothesized that radiation-induced disruption of the BBB might enhance retention of vasculardelivered therapeutic reagents within the targeted tumor tissue. As a proof of principle, it was
shown that TAX-loaded Filomicelle itself could not suppress the growth of GBM-derived tumor
in brain tissue (intracranial tumor) (Fig. 2-4A), whose cells can be killed by the drug-loaded
particles when they form a tumor in subcutaneous tissue. Only when combined together,
Filomicelles with highest possible TA loading and focused radiation against brain tumor tissue
could suppress the intracranial tumor growth and increased survival of the tumor-bearing mice
(Fig. 2-4B)).

2-4. Conclusions
Flexible Filomicelles composed of novel amphiphilic diblock copolymer OCLA is shown to be
an effective delivery vehicle for widely used chemotherapeutic Paclitaxel (TAX), and resulting
drug delivery system successfully suppressed the tumor growth at flank sites where tumor tissue
is composed of leaky vasculature and therefore holds EPR effect. The issue of poor therapeutic
effect by TAX-loaded Filomicelles against intracranial tumor due to physical block of BBB can
be overcome by directly disrupting the BBB by focused radiation therapy. The presented results
here successfully show extended survival of intracranial tumor-bearing mice. Although detailed
study with complete set of controls is required, combination therapy of drug-loaded nanoparticles
and radiation therapy represents a promising treatment for still detrimental brain cancer.
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2-4. Materials and Methods
Cells
Human lung carcinoma A549 cells were purchased from ATCC (Manassas, VA) and cultured
using Ham’s F-12 medium (Invitrogen) supplemented with 10% fetal bovine serum (FBS, Sigma)
and 1% penicillin/streptomycin (P/S, Invitrogen) at 37 C with 5% CO2. Human glioblastoma
maltiforme (GBM) U251 cells were kind gift from Dr. Jay Dorsey’s lab at Radiology department
of the University of Pennsylvania. U251 cells are grown in high glucose DMEM with 10% FBS.

Polymer Synthesis and Characterizations
Amphiphilic di-block copolymer denoted as OCLA corresponds to poly(ethylene glycol)block-poly(ε-caprolactone-random-D,L-lactide) (PEG45-b-P(CL92-r-LA21), where the subscript
for each polymer block indicates the degree of polymerization of respective blocks. In terms of
molecular weights, PEG MW is 2000 and the polyester block is 12,000 g/mol, denoted as OCLA.
Copolymers were synthesized by standard ring opening polymerization of ε-caprolactone and
D,L-lactide monomer using MePEO (2000 g/mol) as initiator and stannous octoate as catalyst .
Briefly, freshly distilled ε-caprolactone (2.19 g, 1.92 x 10-2 M), D,L–lactide (0.312 g, 2.15 x 10-3
M) and Me-PEO (2000 g/mol) (0.4166 g, 2.17 x 10-5 M) calculated based on the desired PEO45b-P(CL92-r-LA21) block ratio and stannous octoate (15 mg, 3.7 x 10-5 M) were taken in a
previously flamed, argon -purged glass ampule (10 mL). The ampule with reactants was further
argon -purged for a few minutes, vacuumed for 15-20 minutes to eliminate the trace amount of
moisture and sealed under vacuum. The polymerization reaction was allowed to proceed for 6
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hours at 140 °C in oven. The reaction was terminated after cooling the ampule to room
temperature.
The newly synthesized OCLA polymer was assessed from 1H NMR spectra obtained
from a Bruker NMR360 spectrometer using deuterated chloroform (CDCl 3) as solvent. The
molecular weight distribution of the synthesized polymer was determined by gel permeation
chromatography using a Waters GPC system equipped with a Waters 1215 binary pump and
Waters 2414 refractive-index detector. Separation was performed using Styragel HR2 column,
calibrated with polystyrene standards and tetrahydrofuran as solvent.

Filomicelle preparation and paclitaxel loading
A solvent evaporation method was then used to generate the filomicelles, which were combined
with paclitaxel in methanol, dialyzed against PBS and filtered by extrusion to remove any
paclitaxel aggregates to thus generate the drug-loaded nanocarrier formulation. Detailed
information on the synthesis, purification, and analysis of the paclitaxel-loaded nanocarrier is
provided in the Supplemental Section. For DLN preparation, the polymer concentration was 4
mg/ml and paclitaxel was added to achieve polymer/paclitaxel ratio (w:w) of 20:1. HiDLN started
with 20 mg/ml with paclitaxel added to 32:1. Increased addition of paclitaxel does not lead to
better loading because of precipitation of polymer and paclitaxel.

Paclitaxel quantitation in Formulations
A Shimadzu HPLC system (Shimadzu Corporation, Japan) equipped with an inline DGU-
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20A3 vacuum degasser, LC-20AB binary high pressure pump, SIL-20AC high speed autosampler
and a pinnacle® DB C18 reverse-phase column (4.6 Å~ 150 mm) was used to detect and quantify
paclitaxel in worm formulation. Briefly, 20 μL of sample was injected to the HPLC system and
eluted by a mobile phase consisting of acetonitrile and water with 0.1% of trifluoroacetic acid at a
flow rate of 1 ml/min at 35 °C. In gradient elution, the starting acetonitrile concentration was
50% and increased to 60% within 15 min at a constant rate. The detection was performed at
λ=228 nm and quantified using a diode array detector (SPD M20A, Shimadzu). A standard curve
was prepared from paclitaxel at concentration of 0.002, 0.01, and 0.05 mg/ml. Data was acquired
and processed with LC solution chromatography software from Shimadzu Corporation. Paclitaxel
- loaded OCLA worm micelles was mixed with acetonitrile and water at a ratio of 50:50 to break
the micelle structure and solubilize the paclitaxel followed by the HPLC analysis using the
standard curve described above.

In vitro cytotoxicity assay
24 hours prior to starting TAX treatment, 5000 glioblastoma cells were seeded into wells of 96well plate (Corning). Dilution series of Fillomicells, polymersomes and free TAX drug were
added to wells and incubated at 37 C with 5% CO2 for 48 hours. Cell viability was tested using
conventional MTT assay. Briefly, cells were incubated at 37 C with 5% CO2 for 4 hours after
adding 20 L of 5 mg/mL Thiazolyl Blue Tetrazolium Bromide (Sigma) to 100 L of cell
solution. After discarding the solution, 100 L DMSO was added to dissolve crystal of reduced
Thiazolyl Blue Tetrazolium Bromide. After incubation on a rocker at room temperature,
absorbance at 565 nm was read corresponding to the number of viable cells in a well.
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Flank and Intracranial tumor establishment
Mice were injected subcutaneously with U251 cells with firefly luciferase gene at a site
superficial to the scapulae bilaterally and superficial and medial to the hip joints bilaterally. The
mice were anesthetized with an IP injection of ketamine/xylazine at a dose of 140mg/kg and
10mg/kg respectively and then placed on their stomach with their limbs symmetrically arranged
such that their feet are pointed cephalad. Once the mouse was sufficiently anesthetized so that no
response was elicited from a light pinch of the rear foot, the site of injection was cleaned with
alcohol. Using aseptic technique, an injection of 100 microliters of a cell suspension containing 2
x 106 tumor cells along with DMEM media was administered using a 26 gauge 5/8” needle into
each site. No closure was necessary.

In vivo treatment of GBM-derived tumors with TAX-loaded Filomicelles
In experiments to test the efficacy of paclitaxel-loaded nanobiopolymer combined with
fractionated radiation therapy, DLN was given as a 1 mL intraperitoneal (IP) injection every other
day for 17 days. Mice received up to 29% of the daily maximum tolerated dose (MTD) of IP
paclitaxel (Kozler and Pokorny, 2003; Weissleder and Pittet, 2008), or 5.89 mg/kg, per treatment.
For tumor evaluation, the fully anesthetized mice received a subcutaneous injection of 60
microliters of pharmaceutical-grade D-luciferin (50 mg/mL). Imaging via the IVIS Lumina II
bioluminescence imaging system system commenced at 5 minutes after the luciferin injection.
The mice were repeatedly imaged over a span of 30 minutes to determine the maximum
luminescence intensity in photons/second, a surrogate marker for the size of the tumor(s). A
volume of interest (VOI) was drawn around each tumor and a background VOI was drawn on the
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animal in an area known to be free of tumor to generate a background corrected bioluminescence
flux value for each tumor at each given time point.
Focused radiation was applied against mice in a custom-made plastic mouse bed
equipped with a stereotactic head immobilizer that integrates with the Small Animal Radiation
Research Platform (SARRP) (Xstrahl, Surrey, United Kingdom). The anatomy of the skull and
brain was calibrated via the onboard cone-beam CT. The location of the tumor was determined by
bioluminescent imaging, and the skull was tattooed to define the beam location. Radiation was
administered as four daily fractions of 3 Gy each with a rate of 0.1 Gy/min after anesthesia with
ketamine/xylazine at a dose of 140 mg/kg and 10mg/kg, respectively. All these techniques helped
ensure day-to-day reproducibility and allowed optimally precise radiation therapy. Mice were
given 1 mL IP injections every other day for 34 days (17 total treatments) beginning on day 1 of
radiation. TAX dosage corresponds to 48% of the daily MTD of intraperitoneal paclitaxel, or 9.55
mg/kg per treatment. This dose was roughly equivalent to 42% of the MTD given to human GBM
patients undergoing concurrent treatment with free paclitaxel and RT.
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Figure 2-1. Basic characterization of Filomicelles
Representative fluorescence microscopy snapshot of wormlike filomicelles made with OCLA and
labeled with fluorescent dye. Scalebar 10 μm. (C) Contour length distribution of several hundred
OCLA (2, 12) Filomicelles. (D) Taxol loading and release by two different methods fitted with
two first order functions for a burst release phase.
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Figure 2-2. Summary of cytotoxicity assay with TAX-loaded polymer formulations with
distinct morphologies
(A) Three cell lines of glioblastoma were incubated with various TAX-loaded polymer
formulations with distinct shapes: spherical micelles, polymersomes and Filomicelles as well as
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unloaded carriers. IC50 was measured using the fitting curve and summarized in (B).
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Figure 2-3. Tumor shrinkage with TAX-loaded Filomicelles
Nude mice with two flank tumors made of U251 cells were treated with TAX-loaded Filomicelles
over a month when the treatment completely suppressed the growth of tumors.
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Figure 2-4. Combination therapy of TAX-Filomicellle and focused radiation improved
survival rate of orthotopic brain tumor-bearing mice
(A) Unlike the case with tumors in subcutaneous tissue, TAX-loaded Filomicelles almost failed
to cure the mice with intracranial tumors, which requires circulating particles to cross over blood
brain barrier in brain endothelia for effective treatment. (B) Graph showing overall survival of
mice with brain tumors that received treatment with optimized radiation therapy techniques alone
(“sRT”) or sRT in conjunction with higher dose DLN (“hiDLN”) incorporating paclitaxel. The
table below lists the median and mean survival of each group of treated mice. The combined
DLN and optimized radiation therapy techniques resulted in significantly improved mean and
median survival compared to mice receiving the radiation therapy alone (p<0.05). (* Most of the
mice treated with combined hiDLN and sRT remained alive, in excellent condition, gaining
weight, and with no detectable tumor, and thus have not yet reached maximal survival. Therefore,
the listed median and mean survivals for “sRT + hiDLN” are those calculated at the end of 120
days).
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Chapter 3: Enhanced Tumor Accumulation with Nanoparticle
with CD47
Portion of this work contributes to Rodriguez et. al., submitted.

In this chapter, the surface of polystyrene beads is modified to achieve longer blood circulation
with integrin-associated protein called CD47. CD47-attached beads with hundreds of nanometer
in size were loaded with anti-cancer drug paclitaxel (TAX), and the drug-loaded particle was
tested first for in vitro cytotoxicity against human lung carcinoma A549. A549 cell was injected
into immune-deficient mouse, whose spleen-derived immune cells can still recognize human
CD47, to establish subcutaneous tumor. TAX-loaded polystyrene beads with CD47 or CD47derived peptide were injected into tumor nearing mice for testing their capability to suppress the
tumor growth. Anti-tumor effect of our modified beads was compared with the conventional
formulation of Cremophor EL.

3-1. Introduction
Macrophages engulf invading microbes and dying cells in a highly coordinated and active process
that evolved over eons and occurs also now in foreign body responses to injected particles and
implants. This clearance function of phagcoytes is delayed but not eliminated by dense ‘Stealth’
brushes such as with polyethylene glycol (PEG) on circulating nanoparticles and liposomes used
in therapeutics and imaging (Bartlett et al., 2007; Klibanov et al., 1991; Photos et al., 2003).
Coating with PEG of (<500 nm) indeed helps to delay rapid clearance and to thereby provide
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more time for circulation through disease sites such as tumors, but neither PEG nor targeting
groups stops the adsorption of serum proteins such as IgG (Table S3-1) nor the subsequent
clearance of particles from the circulation by macrophages in the spleen and liver (Bartlett et al.,
2007; Klibanov et al., 1991; Photos et al., 2003; Rossin et al., 2008; Turk et al., 2004). Delivery
to disease sites can also be limited by phagocytic uptake by tumor-associated macrophages for
example (Turk et al., 2004), and the acquired immunity to foreign polymers has become an
additional concern (Armstrong et al., 2007). In contrast, ‘self’ cells and tissues are in constant
contact with and well-tolerated by macrophages, which has suggested critical mechanisms of self
recognition. Here we describe a reductionist approach to a synthetic but humanized ‘Active
Stealth’ peptide that specifically binds and signals ‘Self’ to phagocytes in blocking clearance of
particles as small as viruses.
CD47 glycoprotein is a putative ‘Marker of Self’ (Oldenborg et al., 2000) normally
expressed on all cell membranes in humans, mice and other higher organisms (Bentley and
Adams), and it often associates in cis with integrins (Brown and Frazier, 2001) and in other
species-specific, immunogenic macrocomplexes on cells (Bruce et al., 2003; Mouro-Chanteloup
et al., 2003; Subramanian et al., 2006). Mouse knockouts of CD47 (mCD47) are surprisingly
viable, but when red blood cells from these mice (mRBCs) are injected into the circulation of
control mice, the deficient cells are cleared within hours by macrophages of the spleen compared
to normal mRBC that circulate for weeks (Oldenborg et al., 2000). CD47’s extracellular domain
interacts with CD172a (SIRP: Signal Regulatory Protein ) on phagocytes (Brown and Frazier,
2001), and the binding proves species-specific (Subramanian et al., 2006) in part because SIRP
is highly polymorphic within a species (Takenaka et al., 2007). Indeed, NOD.SCID strains of
mice happen to express one variant of mouse-SIRPα that cross-reacts with human-CD47, which
explains why human hematopoietic cells engraft and circulate in NOD.SCID better than any other
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mouse strain (Strowig et al.; Takenaka et al., 2007). In vitro, the CD47-SIRP interaction
inhibits mouse macrophage uptake of antibody-coated mRBCs (Oldenborg et al., 2000) as well as
human macrophage uptake

of both human-RBC and human-CD47 (hCD47)-coated

microparticles (Tsai and Discher, 2008).
Minimizing the 117 amino acid, recombinant hCD47 domain to a binding site peptide could
provide, we thought, the clearest evidence that binding and signaling of hCD47 to mSIRP is the
molecular mechanism of inhibition in vivo. Our first guess design was a 21 amino acid ‘Self’peptide, which was simulated for stability and then synthesized with the aims of (i) minimizing
species specificity (Subramanian et al., 2006), (ii) eliminating the glycosylation of CD47 that
impedes binding (Subramanian et al., 2007), and (iii) developing Scrambled, inactive
peptides. Biotinylation on an amino-terminal PEG linker provided a means of attachment to
Streptavidin-beads for in vivo studies.
We address whether human-CD47 and a synthetic ‘Self’ peptide on such small particles
can minimize phagocytic uptake and thereby enhance delivery to tumor in vivo here using
NOD.SCID/Il2rg-/- mice (NSG). TAX was loaded into the sub-micron polystyrene particles
modified with human-CD47 or ‘Self’ peptide on surface. Extended blood circulation of the
particles with CD47 or ‘Self’ peptide is expected to lead increased tumor accumulation due to
EPR effect. Therefore those particles were tested for in vitro cytotoxicity and in vivo tumor
shrinkage using subcutaneous tumor model. Our reductionist approach eliminates confounding,
biological factors on cell membranes (eg. integrins), and the results with a minimal ‘Self’ peptide
constitute a first example of a synthetic, human ligand that binds and signals to phagocyte
receptors to passivate macrophages.
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3-2. Results and Discussion
3-2-1. CD47 Enhances Tumor Accumulations of the Opsonized Particles In Vivo
Polystyrene beads were pre-labeled with hydrophobic near infrared dye (DiR) to enable noninvasive detection of particles in mice at different time points after injection. Since NSG mouse
cannot produce immunoglobulin (Friedl et al.), which is one of the most common opsonin (table
3-1), the beads with strept-avidin coating on the surface was always attached with anti-avidin
antibodies to mimick the opsonized state. Opsonized beads was injected into NSG mice in the
presence of CD47 or ‘Self’ peptide also on the surface to see if those beads could result in
increased tumor accumulation compared to beads with only IgG. Although still large part of the
injected beads trapped in spleen and liver (Fig. 3-2A), CD47 and ‘Self’ peptide enhanced the
tumor accumulation in the similar level. As early as 10 min after tail vein injection of
nanoparticles, CD47- and ‘Self’ peptide-attached beads gave mean tumor intensities 2-fold above
those of non-injected mice while control beads gave background-level signal (Fig. 3-2B). With
CD47- and ‘Self’ peptide beads, the fluorescence at every time point is significantly higher than
control beads (p < 0.05), and the increase fits to first order kinetics ( = 52 min), consistent with
enhanced perfusion that is limited by progressive clearance. Notably, at 40 min, both CD47- and
‘Self’ peptide beads give ~10-20 fold higher signals than controls.
Tumors and other major organs in one experiment were subsequently excised at 35 min
post-injection and imaged in order to remove background from nearby tissue in the region-ofinterest (Fig. 3-2C). The ‘Self’-beads and CD47-beads show 16- to 22-fold enhancement above
the very low signals obtained with control opsonized beads, with no statistical difference between
‘Self’-peptide and hCD47. The fraction of nanobeads in the blood within the tumor is small (Fig.
3-2C, inset), and so the majority of signal derives from beads that have accumulated in the tumor,
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most likely by Enhanced Permeation and Retention (EPR) through the leaky vasculature
characteristic of many solid tumors (Cabral et al.; Matsumura and Maeda, 1986).
Scrambled peptide showed rapid clearance, with only 0.2% of injected particles still in
circulation after 40 min post-injection. Total number of injected beads was estimated 10 7 from
flow cytometry analysis, which was correlated with their intensity of DiR using LICOR Imaging
system. DiR signals from both blood and tissues, which were collected at 40 min post-injection,
were nicely detected under LICOR (Fig. 3-3A). Tumors composed of tdTomato-expressing A549
cells emits detectable fluorescence at 700 nm under LICOR measurement, with intensity having
linear correlation with both tumor mass and intensity at 800 nm (Fig. 3-3B). This made possible
to estimate background level at 800 nm emission and the number of DiR-labeled beads
accumulated in tumors and other organs (Fig. 3-3C). This represents the peptide sequence
specificity for the capability of avoiding immune cell clearance, requiring the specific interaction
between CD47 or its binding site sequence and SIRP on immune cells.

3-2-2. In Vitro Cytotoxicity of TAX-loaded Nano-beads with Surface Modifications
The ultimate goal of this study is to see if CD47 or ‘Self’ peptide can avoid the clearance by
immune cells during circulation and eventually improve the drug delivery capacity for the nanosized particles. Paclitaxel (TAX) as a model drug was successfully loaded into polystyrene beads
used in this study through hydrophobic interactions. Various surface modifications were applied
to the particles with IgG and other molecules such as CD47, PEG, and antibody against hCD47.
The attachment of CD47 does not affect cytotoxicity of the TAX-loaded particles (Fig. 3-1),
showing similar IC50 as beads with only IgG (IC50 = 0.5 g/mL). Anti-hCD47 antibody was
attached on the beads’ surface via biotin to see if the antibody can recognize CD47 molecule
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expressed on the surface of tumor-comprising A549 cells, thereby serving as a targeting moiety in
vivo. Interestingly, beads with anti-CD47 showed slightly high cytotoxicity similar to widely
used TAX formulation using Cremophor EL, essentially constituted with small molecule
surfactant. Free TAX showed the lowest IC50 among the tested samples, while PEG-coated beads
showed the highest value (or lowest cytotoxicity) possibly because of the steric repulsion by PEG
blush on the surface.

3-2-3. Enhanced Tumor Shrinkage with TAX-loaded Beads with CD47 or ‘Self’ Peptide
Lastly, clearance-avoiding nanobeads loaded with anti-cancer drug TAX were injected into the
tail vein of tumor bearing mice to see if those drug-loaded particles can deliver their cargo to the
tumor tissue and release drug molecules to kill the cancer cells. TAX is very potent anti-cancer
drug as shown in Fig. 3-2, and even opsonized beads could suppressed the growth of A549
subcutaneous tumor after 3 daily doses (Fig. 3-4A). CD47 beads showed successful shrinkage of
the tumor, almost similar level to the conventional TAX formulation with Cremophor EL.
TAX/Cremophor EL formulation is known to cause adverse effects on healthy cells, and we also
observed necrosis in the tail. All mice injected with TAX-loaded CD47 beads showed no
evidence of significant side effects, giving consistent shrinkage of the tumors with statistically
significant difference from opsonized beads. ‘Self’ peptide-attached beads could also show
similar capacity for tumor shrinkage, and with the help of targeting capability of anti-hCD47 they
achieved quicker anti-tumor effect compared to TAX/Cremophor EL detected at 1 day postinjection. Although further study for optimizing dosing pattern is required, the presented result
suggests the remarkable advantage of the combination of targeting moiety and CD47 to achieve
quick tumor shrinkage.
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3-3. Conclusions
Phagocytes are found in all tissues of the body in addition to the spleen and liver, and they have
key roles in recognizing and clearing foreign cells and particles as well as contributing to
inflammatory responses with cytokine release and oxidative burst. Recently study from Discher
lab showed that implantation of polyurethane slabs coated with hCD47 will inhibit oxidation of
the polymer [30], indicating a general capacity of this ‘Marker of Self’ to passivate via active
signaling to Macrophages – a form of ‘Active Stealth,’ via interaction between CD47 and its
receptor SIRP on Macrophages.
Understanding of the CD47-SIRPα interactions is beginning to find application in
disease, with blocking of CD47 on tumor cells allowing tumor-associated macrophages to attack
the tumor (Willingham et al.). CD47 or even ‘Self’ peptide, which is designed from CD47
binding sites, on nanoparticles should likewise limit uptake by tumor-associated macrophages of
nano-particle imaging agents and therapeutics and thus improve delivery to cancer cells. The
presented study using CD47- or even ‘Self’ peptide-coated nanobeads loaded with anti-cancer
drug TAX showed similar level of cytotoxicity in vitro to conventionally used TAX formulation
with Cremophor EL but superior tumor shrinkage capacity in vivo, consistent with the improved
accumulation of Active Stealth beads in tumor tissue, proved by non-invasive imaging study with
near infrared dye. Presented results encourage the use of CD47 or even ‘Self’ peptide for
avoiding the clearance by immune cells, which has been under-studied area probably due to
strong belief in PEG stealthiness, for the achievement of advanced drug delivery system. The
combination use of PEG for avoiding opsonization and CD47/’Self’ peptide for avoiding
clearance of delivery particle after eventual opsonization may contribute to the new step toward
clinical use of drug delivery system for cancer therapies.
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3-4. Materials and Methods
Beads sample preparation
Streptavidin-coated polystyrene beads of 160 nm radius (Spherotech) were washed and blocked
3x in PBS plus 0.4% BSA. First, beads were labeled with near infrared dye DiR at room
temperature. After washing, recombinant, biotinylated human-CD47 or ‘Self’ peptide was
attached to the beads and then rabbit anti-streptavidin conjugated with FITC was added as an
Opsonizing IgG-antibody (Rockland Immunochemicals). Anti-hCD47 antibody was added
afterwards, if necessary. Beads were incubated at room temperature for 30-45 min to let those
molecules attach to the beads surface, then washed and re-suspended in PBS for injection.

Live and ex vivo imaging of DiR beads
Human lung carcinoma A549 cells (106) were suspended in PBS with 25% Matrigel (BD
Bioscience) and injected subcutaneously into flank sites of each NSG mouse. After about 5
weeks, the tumor-bearing mice received tail vein injections of DiR dye-coated beads with surface
modifications as above. Fluorescent intensity from DiR dye in tumor areas was monitored at
10min, 40min, 90min and 120min, using Xenogen IVIS Spectrum Imaging System (Caliper Life
Science) and Living Image Software (Cliper Life Sciences) for later analysis. After 120 min postinjection, the mice were sacrificed for harvesting tumors and blood. Harvested tumors and blood
were imaged with the LICOR Odyssey imaging system to measure the number of DiR-labeled
beads.
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Paclitaxel loading on beads
108 polystyrene beads were suspended in 300 L Milli-Q water. 5 L of 4.5 mg/mL paclitaxel
(LC Laboratories) in methanol was added to the beads to achieve 75 g/mL concentration. After
overnight incubation at room temperature and following spin-down, beads were re-suspended in
20 L of PBS for concentration. 10 tubes prepared in the same way were combined to achieve 10 9
particles suspension in 200 L PBS for a single injection. If necessary, beads surface was
modified by attaching molecules as shown above.

MTT Aassay
5000 A549 cells were seeded on wells of 96-well plate, 24 hours prior to drug treatment. Cells
were treated with series dilution of beads samples loaded with paclitaxel, starting from 7.5
g/mL. After 24 hours incubation at 37C with 5% CO2, cells were washed once with PBS and
added with 100 mL growth medium and 20 L of 5 mg/mL Thyazolyl Blue Tetrazolium Bromide
(Sigma). After 4 hours incubation at 37C with 5% CO2, purple crystal in the cells were
solubilized by adding 100 mL DMSO. Absorbance was read at 560 nm.

Tumor treatment study
About a month after A549 cell inoculation, tumor-bearing mice were treated with 4 daily
injections (i.v.) of paclitaxel-loaded beads with surface modifications at a dose of 7.5 mg/kg.
Tumor size was measured on daily basis, making an estimation of volume with
Tumor volume = ½ * (major axis) * (minor axis)2
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As a positive control for tumor shrinkage, paclitaxel solubilized with Cremophor EL (Sigma) was
injected at 22 mg/kg.

Figure 3-1. Cytotoxicity of TAX-loaded nanobeads with different surface modifications
A549 cells were incubated with TAX-loaded polystyrene beads for 24 hours to test their
cytotoxicity, as well as control TAX formulation with Cremophor EL or free TAX. Beads were
attached with IgG and additional molecule as specified in the upper right of the panels (‘IgG’
represents no additional molecule). IC50 of each sample was roughly determined by the trend line
as shown in each panel.
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Figure 3-2. ‘Self’-peptide and human-CD47 enhance tumor imaging by Near-Infrared
particles
(A) NSG mice with flank tumors of A549 lung-derived cells (black circles) received tail vein
injections of nanobead mixtures in which one bead type is labeled with DiR fluorophore. Images
of live mice and calibration standards were taken with a Xenogen imager. Tumor-bearing mice
have persistence ratios of particles in blood at 35 min, even though many particles are seen in
spleen and liver. (B) The tumor region was estimated in the brightfield image for quantitation of
total fluorescence at each time point, and all results for ‘Self’-peptide and CD47 were combined
in the fit. Results are cumulated from all tumors from three different sets of tumor-bearing mice.
N, Number of tumors. (C) Tumors were harvested from one set of tumor-bearing mice for ex
vivo quantitation by an Odyssey imaging system. For control, N = 2; for ‘Self’-peptide, N = 4;
and for CD47, N = 6 tumors. Inset bargraph shows the high percentage of nanobeads in the
tumor compared to an upper bound for the nanobeads in the blood vessels within the tumors (n =
2).
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Figure 3-3. Estimation of the beads number in tumor/spleen/blood 40 min after injection
(A) Representative image of tumor, spleen and blood (in 96-well plate) from the mice injected
with opsonized beads with Scrambled peptide, taken by LICOR imaging system. 10 L of blood
sample was diluted with 90 L of PBS to avoid too strong local intensity and saturation. Blood
was collected at 10 and 40 min post-injection to compare the number of beads remaining in the
circulation. (B) Tumor of tdTomato-expressing cells were measured for fluorescence emission at
both 700 and 800 nm. 700 nm represents the signal from tdTomato, nicely correlating with tumor
mass (not shown) and therefore background at 800 nm. The background subtraction was
performed based on the estimation from the equation shown in the graph. (C) Emission intensity
at 800 nm was used for the estimation of the number of beads. The calculation indicates
remarkable clearance by spleen macrophages of beads with Scrambled peptide, leading to the
idea that specific interaction between CD47 (or ‘Self’ peptide) and SIRP is needed for strong
accumulation in tumors.
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Figure 3-4. Tumor shrinkage with TAX-loaded nanobeads with CD47 or ‘Self’ peptide
NSG mice were injected with TAX-loaded nanobeads as well as positive control formulation of
TAX/Cremophor EL, (A) with 3 daily doses and tumor size monitoring every day until day 4 or
(B) single injection and observation on following day in case of beads also attached with antihCD47. Tumor size (volume) was estimated as shown in Method section and relative value was
calculated with the tumor size from mice injected with control IgG beads.
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Table. 3-1 List of papers studying with PEG-coated particles and showing opsonization
(binding) with IgG
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Chapter 4: Lamin-A levels limit 3D-migration but protect
against migration-induced apoptosis

Cell migration through dense tissue and matrix requires a cell and its nucleus to contort and flow.
A strong dependence of 3D migration on the variably expressed nucleoskeletal protein Lamin-A
is revealed here across widely different normal and cancerous cell types relevant to regeneration
and disease. Crawling through tissue is modeled by motility through micro-pores, with small
decreases in Lamin-A producing large increases in net migration. Surprisingly, the largest effects
occur when Lamin-A is low relative to constitutive Lamin-B’s. Nuclear shape changes after
micro-pore migration as well as nuclear response times in micropipette aspiration scale strongly
with the ratio of Lamin-A:Lamin-B across cell types, revealing Lamin-A’s role in nuclear
plasticity and Lamin-B’s role in nuclear elasticity. Lamin-A also protects against apoptosis
induced by micro-pore migration, with deeply deficient cells showing defects in stress-resistance.
Xenografts provide in vivo insight and show moderately low Lamin-A levels promote growth of
the graft. The nuclear lamina thus acts as a physical impediment to motility and also promotes
survival in withstanding the mechanical stresses of migration.

4-1. Introduction
Cell motility in adult animals underlies a wide range of critical processes, including trafficking in
tissue repair and disease. In the “invasion-metastasis cascade” (Weinberg, 2007), for example,
cells in the tumor periphery crawl through surrounding tissue and extracellular matrix (ECM) to
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divide or perhaps metastasize by squeezing into narrow vessels. Multipotent stem cells in the
bone marrow likewise transmigrate into blood and other tissues far from their usual niche and
have potential roles in tissue regeneration (Pittenger and Martin, 2004) as well as cancer
(Houghton et al., 2004; Nakamizo et al., 2005). Successful migration requires cells to survive
large distortions as they make their way through ECM or across a basement membrane (Fig. 41A), and the largest single organelle in every cell is typically the nucleus, which tends to be solidlike and stiff (Dahl et al., 2005; Lammerding et al., 2006; Pajerowski et al., 2007). In light of the
high stresses generated by the cytoskeleton in crawling through matrix (Mierke et al.), we
hypothesized key roles for nuclear mechanics in 3D-migration and cell survival.
Lamins are intermediate filaments (IFs) in the nuclei of most adult animal cells and have
multiple roles as they modulate gene expression and also provide physical support akin to other
IF proteins (eg. keratins in nails) (Dechat et al., 2008). A meshwork of Lamins assembles in
nearly all cells with expression from three genes: LMNA which is alternatively spliced to Lamins
-A and -C, and LMNB1 and LMNB2.

An instructive exception is the highly motile

polymorphonuclear leukocyte (PMN) that lacks A-type Lamins (Olins et al., 2001). PMNs
migrate through micron-sized pores of the endothelium and through dense tissues, as modeled in
vitro with chemotactic gradients that induce PMN transmigration through cell monolayers (Nash
et al., 1987), and the flexibility of the multi-segmented nucleus is thought to facilitate such
motility (Olins et al., 2001). Terminal differentiation to PMNs involves downregulation of
Lamins, but PMN-neutrophils also survive for only days (Pillay et al., 2010). Lamin-A is
generally the most variable Lamin isoform in comparisons of normal tissues (eg. Jung et al.,
2012), and so altered Lamin-A levels in tumors (Kaufmann et al., 1991; Willis et al., 2008) are
perhaps understandable and perhaps tempting to view from a PMN perspective. Higher rates of
colon cancer recurrence indeed associate with low Lamin-A (Belt et al., 2011).
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However,

malignancy of squamous cell and basal cell carcinomas as well as colorectal cancer are all
associated with elevated Lamin-A (Foster et al., 2010; Tilli et al., 2003). In light of such
seemingly contradictory correlations, we sought to clarify mechanistic roles for Lamin-A in 3D
migration across a broad range of cell types that exhibit mesenchymal-type motility.
Mouse knockouts for all of the Lamins are surprisingly viable in early development, but
all animals succumb prematurely. Lamin-A knockout mice develop all tissues, but death at age
5-6 weeks with evidence of dystrophic heart and muscle (Sullivan et al., 1999) indicates more
severe defects than the prototypical mdx dystrophic mice that survive for almost 100 wks
(Chamberlain et al., 2007). Lamin-B1, B2 knockouts have been studied recently and once again
show all embryonic lineages develop, but mice die at birth with poorly innervated diaphragm,
small body size, and a brain that fails to develop past embryonic day 18.5 (Coffinier et al., 2011;
Kim et al., 2011). Apoptosis of neuroprogenitors was particularly apparent in migration from the
inner cortex through the dense mid-cortex, which is notable because in wildtype migration of
neuroblasts through the developing cortex, the nucleus can be stretched by almost 5-fold for
many minutes at a time (Pajerowski et al., 2007; Tsai et al., 2005). Likewise with invasive
migration of glioblastoma, the nucleus appears distorted by at least 2-fold as these cells exert
contractile forces to push or pull nuclei through tissue (Beadle et al., 2008). Lamin isoform ratios
ultimately prove here to be predictive of the Lamin- A sensitivity of 3D-migration through tissuelike, small diameter pores both in vitro and in vivo.

4-2. Results
4-2-1. 3D migration is sensitive to Lamin-A levels and can be biphasic
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The three human cell types in focus here are highly diverse in their mesenchymal-type motility
(Fig. 4-1B, left). Glioblastoma-derived U251 cells migrate 35-fold faster through 3 m pore
transwell filters than lung carcinoma derived A549 cells while bone marrow-derived, primary
mesenchymal stem cells (MSCs) are almost 8-fold faster than A549s. Rigid, micro-porous filters
(3-8 m pores) seem appropriate based on measurements of the elasticity of flank xenografts,
which are indeed stiff (Fig. S4-1) relative to a typical nucleus (Pajerowski et al., 2007), and also
based on the apparent micro-porosity of decellularized xenografts as well as known capillary
diameters (Fig. 4-1A inset). In 2D-migration, speeds of these same cell types vary by just 2-fold
but do follow the same trend as in 3D-migration: U251 > MSC > A549 (Fig. S4-2). While 2D
speeds are 10-20 m/ hr, very few cells cross the 22 m-thick filters on the same time scale,
consistent with impeded migration through 3 um pores.
The three cell types also have highly distinct Lamin profiles (Fig. 4-1B, right). We used
mass spectrometry (Maloney et al.) to measure for A549s as mean Lamin-A:B ratio of 2.3 (Fig.
4-1B), which is a measurement that cannot be done by antibody methods and indicates of course
that Lamin-A is the dominant isoform in A549s. MSCs have 3.5-fold higher A:B while the U251
cells have 3.1-fold less (Fig. S4-3), so that Lamin-A:B varies by more than 10-fold across cell
types: MSC > A549 > U251. Additional studies show that this ratio scales with the stiffness of
the tissue of origin, with brain being softer than lung, and lung softer than bone (Swift,
submitted).

Quantitative immunofluorescence measurements for B-type Lamins as well as

quantitative Western blots further show that A549 have the lowest Lamin-B while MSCs express
the most, although variations in Lamin-A are larger. From the A:B ratio and the normalized
amounts of Lamin-B, total Lamins (A + B) are also readily calculated (Fig. S4-3). The various
measurements thus establish that wildtype migration and Lamin abundance are significantly

59

different between the three cell types. Nonetheless, the Lamin profiles are shown below to
predict a surprising trend in the sensitivity of 3D migration to Lamin changes.
Knockdown of Lamin-A by transient transfection of short interfering RNA (siLMNA)
was again followed by migration studies.

While 2D-migration was unaffected by partial

knockdown (Fig. S4-2), A549 cells showed a net migration efficiency through 3 m pores that is
biphasic in its dependence on Lamin-A expression. Relative to scrambled siRNA-treated cells in
the same experiment, a partial knockdown of ~50% (siLMNA+) produced the greatest increase in
3D-migration of more than 4-fold (Fig. 4-1C), a trend confirmed with a second siLMNA (Fig.
S4-4A). Overexpression of Lamin-A strongly impeded migration of A549 cells, and followed the
same trend in migration established with partial knockdown:

just ~10% more Lamin-A

suppressed migration by 90%. Knockdown of these over-expressing cells increased as expected
the net migration (Fig. S4-4B), but further overexpression reached the same minimum level of net
migration (see sorting discussion below). Combined with partial knockdown, the range of net
migration seen throughout these studies of A549 cells varies systematically by about 50-fold.
To assess specificity of Lamin-A knockdown, label-free MS was used to quantify the
levels of the most abundant structural proteins after partial knockdown (Fig. 4-1D, Table S4-1):
148 of 169 proteins (88%) differed from control by less than 25%. The transient, siRNA
knockdown of cells was preferred over methods such as transduction with short hairpin RNA
(shRNA), because sustained disruption of Lamins can impact a broad range of cell processes
(Hutchison and Worman, 2004). Lamin-A knockdown here also did not perturb proliferation of
A549 cells (Fig. S4-4C), which is consistent with past findings (Elbashir et al., 2001). In sum,
the partial, transient knockdown revealed only one obvious phenotype, namely enhanced
migration through small micro-pores.
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Knockdown of Lamin-A by ~50% in both U251 cells and MSCs also showed significant
increases in net migration (Fig. 4-1C). While the fold-increase relative to wildtype cells is
smallest for U251s and intermediate for MSCs, to understand the sensitivity to Lamin changes it
is necessary to account for the motility of wildtype cells as well as the real change in total Lamin
levels (Fig.4-1C, inset plot; Fig. S4-3). The slope for each cell type in such a plot reveals the net
migration sensitivity to a Lamin-A change (m3D-sens) after partial knockdown and overexpression,
and this cell-type specific

m3D-sens is seen to vary by almost 20-fold. For a small amount of

change to Lamin-A levels in U251, for example, the net number of U251 cells that migrate
through the constraining pores is much higher than for the other cell types. U251 cells thus show
the greatest sensitivity and MSCs show the least sensitivity (m3D-sens: U251 > A549 > MSC).
This is the same trend as the Lamin-A:B ratio in wildtype cells (Fig. 4-1B), which will be
explained mechanistically in the next section.
One additional and striking feature in Fig.1C is the biphasic dependence of 3D migration
on Lamin-A levels. Very deep knockdown (siLMNA++ treatment) decreases the net migration
of cells through the fibronectin-coated filters by 50% relative to wildtype, without affecting 2D
migration (Fig. S4-2). The biphasic effect is also apparent without fibronectin pre-coating of the
filter and was confirmed with a second siLMNA (Fig. S4-4A). As elaborated in detail below,
3D-migration through small pores but not large pores leads to a net loss in total cell number and
in proportion to knockdown (Fig. S4-4D).

Shape changes of high Lamin-A nuclei are sustained after migration through 3 m pores
In counting cells on the bottom of the 3 m filters, we noticed that nuclear shapes on the bottom
surfaces of the 3 m transwell filters were strikingly elongated and distinct compared to the
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typical elliptical shapes on the top surface (Fig. 4-2A). With 8 m transwell filters, nuclei on the
top and bottom of the filters appeared in shape indistinguishable from healthy 2D cultures and
cells migrating in 2D (Fig. 4-2A, right; Fig. S4-5A), and Lamin-A knockdown had no effect on
net cell migration (Fig. 4-2A, lower right inset graph). For both 3 and 8 m transwell filters,
images showed nuclei partially or fully inside pores, but only for the 3 m pores did we observe
Lamin-A segregation from Lamin-B as the former but not the latter outlines the pore exit (Fig. 42A, lower left inset image). Since the 3 m pores are only about 3% of the average projected
nuclear area of A549 cells (220  50 m2 for A549 nuclei on Top) compared to 23% of 8 m
pores, nuclear shape changes appear far greater in entering the smaller pores.

Sustained

deformation of nearly all nuclei is apparent with 3 m pores, regardless of whether Lamin-A was
knocked down or not. However, for 8 m pores, Lamin-A knockdown had no effect on nuclear
shapes on the bottom of the filters, and knockdown also had no effect on the net migration of
cells (Fig. 4-2A, lower inset). These findings together with those in 2D provided strong evidence
that the moderate perturbations of Lamin-A do not greatly perturb the cytoskeleton, which is
consistent with the proteomic analyses (Fig. 4-1D). More importantly, for the three tested cell
types, sustained changes in nuclear shape correlate with 3D migration sensitivity to Lamin-A.
Importantly, U251 nuclei did not change shape after migration through 3 m pores,
whereas MSCs showed the most extreme elongation of nuclei (Fig. 4-2B inset images; Fig. S45B, C). Changes in circularity of nuclei after migration through 3 m pores were therefore
quantified for the three different cell types, with more distorted nuclei on bottom producing a
negative value for the characteristic ‘Circularity of Nucleus’ (Circ).

Fig. 4-2B reveals a

remarkably strong, exponential correlation between this structural characteristic and the
functional measure m3D-sens for 3D-migration sensitivity to Lamin-A in Fig. 4-1C. The different
Lamin-A:B ratios for the various cell types seemed a more explicit structural basis for both m3D62

sens

and Circ, and Fig. 4-2C confirms the excellent correlation. In particular, wildtype MSCs have

the highest Lamin-A:B and show the greatest nuclear deformation, with strong attenuation after
Lamin-A knockdown (Fig. 4-2C, inset).
These results suggest that A- and B-type Lamin isoforms play separate roles in nuclear
shape and viscoelasticity. When Lamin-B is the dominant isoform as in the U251 cells, the
nucleus readily recovers after deformation through a small pore, behaving reversibly like an
elastic spring (Fig. 4-2C, upper inset schematic). When Lamin-A is the dominant isoform as in
the A549 cells and MSCs, the nucleus deforms in a plastic manner after migration through a
small pore, behaving irreversibly like a viscous fluid in the Lamina. This mobility of Lamin-A
can also help explain its lagging segregation in A549 nuclei (Fig. 4-2A, lower inset). Past
photobleaching studies of GFP fusions of the Lamins had shown Lamin-B1 to be immobile
whereas both Lamin-A and Lamin-C appeared mobile (Shimi et al., 2008), which seems
consistent with the long-time, elastic versus fluid contributions of the Lamins to nuclear shape
changes described here. We had previously quantified the irreversible plasticity of nuclei after
aspiration of a nucleus into a micropipette (Dahl et al., 2005; Pajerowski et al., 2007), and our
mass spectrometry method now allows us to calibrate the Lamin-A:B ratios and determine which
isoform dominates in any given cell type. Thus the plasticity shown here not only results from
active cell migration and correlates exponentially with the sensitivity of 3D migration to LaminA, but the trends can all be understood – and will be shown predictable below – from Lamin-A:B
ratios.

Cell sub-populations sort in 3D migration, with more flexible nuclei promoting migration
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Lamin-A:B levels are naturally variable within cell populations, with a standard deviation/mean
of ~0.25 for the A549 cell line (n > 150). We therefore examined more carefully the Lamin
intensities and nuclear shapes on both sides of the 3 m filters and discovered that A549 cells on
the bottom generally had lower Lamin-A:B levels as well as more distorted nuclei (Fig. 4-3A).
Importantly, similar changes were not observed with the 8 m pores (Fig. 4-2A, S4-5A). Cell
sub-populations with lower Lamin-A thus migrate more quickly through constraining pores.
Previous studies of individual nuclei with micropipette aspiration after Lamin-A
knockdown showed Lamin-A to be important to nuclear elasticity and stability for short times and
high stresses (Pajerowski et al., 2007). Here we tested the Lamin-A dependence of nuclear
deformation using aspiration pressures (Fig. 4-3B) that deform the wildtype nucleus at rates close
to cell migration speeds reported for physically constraining tissue models such as fibrosarcoma
cells in a 3D collagen lattice (~0.75 m/min; Wolf et al., 2003). The ~kiloPascal pressures used
are also similar in magnitude to traction stresses that migrating cells apply to stiff substrates
(Dembo and Wang, 1999). The resulting linear increase in nuclear membrane extension (after 5
min for several pressures) is 3.6-fold steeper after partial knockdown of Lamin-A compared to
control cells (Fig. 4-3B, bottom). This is similar to the ~4-fold difference seen above in active
migration through pores (Fig. 4-1C) of diameter similar to the micropipette and seems consistent
with the migration-based sorting through the 3 m filter of the low Lamin-A sub-population of
cells.
For an even broader examination of the Lamin-A dependence of nuclear mechanics,
micropipette aspiration was applied to all three cell types together with knockdowns and
overexpressing cells (Fig. S4-6A-C). Once an aspiration pressure is applied, the nucleus is
extended to some length over time, and one can either (i) determine the response time, , needed
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to achieve the same extension length for all nuclei, or else (ii) pick a common time and determine
the different aspirated lengths as done above. For the physical plasticity model of Fig. 2C, it is
readily shown that

 = (viscosity / elasticity)

Eq.1

and based on the idea of separate viscoelasticity contributions from Lamin isoforms, we plot 
versus Lamin A:B ratios. For the 10-fold range in Lamin-A:B ratio between cell types, including
cells where A-type Lamins dominate B-type Lamins,  varies by more than 100-fold, with a
similarly strong effect for A549 cells overexpressing Lamin-A (Fig. 4-3C). A steeply positive
power law fit

 ~ [Lamin-A : Lamin-B]2.5

(R2 ≥ 0.85)

Eq.2

reveals the primary contribution of Lamin-A to nuclear viscosity, whereas Lamin-B’s contribute
predominantly to nuclear elasticity.

The range of apparent viscosity measurements with

knockdown cells in Fig. 3C is almost 104-fold, which is similar to the fold-difference in the
viscosities of honey and water.
For the plasticity model of Fig. 4-2C, an effective stiffness E(t) is obtained by re-scaling
the imposed aspiration pressure (or stress) by the aspirated length, which depends on time. E(t)
should increase even if the viscosity increases with higher Lamin-A, but the power law scaling
should be weak if Lamin-A is predominantly contributing as a fluid and indeed: E(t) ~ [LaminA:B]0.5 (Fig. S4-6D). Thus, a moderate decrease in Lamin-A leads to an overall increase in the
flexibility of nuclei and more rapid 3D migration even in the absence of perturbations either to
migration speed in 2D culture (Fig.S4-2) or to other abundant cellular proteins (Fig. 4-1D).
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Lamin-A protects against 3D-migration induced apoptosis
In addition to observing sustained, plastic deformation of nuclei after migration through small
pores, we noticed that the total number of cells on the 3 m filters after 24 hours decreased with
increasing level of Lamin-A knockdown (Fig. S4-4D). No such changes were observed with 8
m filters. These observations and the decreased migration after deep knockdown of Lamin-A
(Fig. 4-1C) prompted the hypothesis that mechanical stresses of migration could induce
apoptosis. A protective role for Lamin-A is reasonable since enhanced apoptosis and necrosis is
reported in vivo with Laminopathies and in in vitro studies (reviewed in: Dahl et al., 2008). Cells
on both sides of the filters were therefore immunostained for cleaved caspase-3, an apoptosis
marker downstream of multiple stress pathways, including mechanical stress (Cheng et al., 2009;
Shive et al., 2002), and activatable within a few hours of insult (eg. staurosporine Zhang et al.,
2004). This is a minimum time scale for cells to migrate the 22 m thickness of the pores (Fig.
S4-2). Imaging indeed showed apoptotic cells with their nuclei still in the pore (Fig. 4-4A
images), which illustrates the coincidence of apoptosis and 3D-motility. With scrambled siRNAtreated cells, only ~1% or fewer cells on top of the filter were apoptotic compared to ~12% of
cells that had migrated to the bottom of the filter (Fig. 4-4A, plot).

Fibronectin had no

statistically significant effect on apoptosis throughout these studies, which suggests that loss of
anchorage from the bottom surface is limiting. The results thus reveal a significant wildtype level
of 3D-migration enhanced apoptosis.
Partial knockdown of Lamin-A led to a significant increase in apoptosis on the bottom of
the filter (Fig. 4-4A, plot), consistent with the > 10% decrease in total cell number after migration
(Fig. S4-4D). Since partial reduction of Lamin-A in A549 cells showed negligible perturbation to
the proteome (Fig. 4-1D), the results support the hypothesis that the nuclear Lamina protects
physically against stress. In this case ‘stress’ is the mechanical stress generated by each cell
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during its migration. Of course, despite these stresses and an increase in %-apoptotic cells, partial
knockdown also produced a 4-fold increase in the net number of migrated cells, which indicates
that the flexibility gains are considerably greater than the compromised stress response.
Deep knockdown of Lamin-A to <10% of wildtype A549 cells showed an average of
30% apoptotic cells that had migrated through the pores (Fig. 4-4A, plot). Decreased Lamin-A
had no significant effect on apoptosis of cells in culture or on the top of the 3 m filters, but
apoptosis in 3D-migration is consistent with the large decrease in total cell number after
migration (Fig. S4-4D). More frequent apoptosis of cells with deep knockdown of Lamin-A
helps to explain the suppressed migration of these cells (Fig. 4-1C star in main plot).
Deep knockdown cells also showed major changes to the proteome (Fig. 4-4B), which is
not surprising given the many interactions of Lamin-A (Broers et al., 2006). Among the abundant,
stress-related proteins that showed large decreases with deep knockdown of Lamin-A was
HSP90, which is a molecular chaperone that accounts for about 2% of protein mass in most
normal cell types. Western blots validated the decrease of HSP90 (Fig. 4-4C). HSP90 interacts
with >200 proteins as well as being involved in responses against DNA damage (Trepel et al.,
2010), which can be caused by applying mechanical stress to cells in culture (Mayr et al., 2002).
Although other proteins of potential relevance changed (see Supplemental Discussion), we
hypothesized that HSP90 provides critical protection against apoptosis induced by 3D-migration
stresses that lead to protein unfolding and/or DNA damage. Cells were pre-treated for one day
with the HSP90 inhibitor 17-AAG (Maloney et al., 2007) and allowed to migrate through 3 m
pores in the presence of the drug. The drug caused 4-fold more apoptosis in sparse cultures of
wildtype cells (Fig. 4-4D). This is significant but much less than half the apoptosis caused by
migration through a pore, which suggests additional apoptotic mechanisms in migration. After
deep knockdown of Lamin-A, additional treatment with 17-AAG increased apoptosis to a level
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similar to that caused by migration through a pore and suggests HSP90 deficits are a major aspect
of apoptotic mechanisms in migration. Importantly, drug treated cells, including both wildtype
and knockdown cells, appeared to enter pores on the top filter but were not detectable on the
bottom side of the transwell filter, whereas control cells gave results included in Fig. 4-4A.
HSP90 is thus downstream of Lamin-A, with inhibited function being a major impediment to
migration as well as cell death.

Lamin-A is low in the periphery of xenografts, and Lamin-A moderation enhances growth
For insights into Lamin levels in in vivo microenvironments, A549 cells were injected into the
flanks of immuno-deficient NSG mice, and after 4 weeks xenografts were harvested and quickly
sectioned into core and periphery sections.

Collagenase treatment was followed by

immunostaining of suspended A549 cells for human-specific Lamin-A and Lamin-B. Flow
cytometry measurement of Lamin levels consistently showed that cells in the cores of tumors (n =
6 tumors) had higher Lamin-A:B than those from the peripheries of tumors (Fig. 4-5A). These
results suggest that cells with more deformable nuclei (due to lower Lamin-A:B) more efficiently
invade into the surrounding tissue, whereas cells with stiffer nuclei remain in the core. Cleaved
caspase-3 in these freshly-derived cells was also measured, but only slightly more cells appeared
apoptotic compared to the small fraction on the upper side of the transwell filters (Fig. 4-4A).
There are of course mechanisms in vivo (eg. macrophages) to rapidly remove apoptotic cells that
do not exist in reductionist culture studies above.
Because partial knockdown of Lamin-A produced a net increase in 3D-migration without
significant changes to the proteome and without offsetting increases in cell death, we next sought
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to assess the possible impact of partial knockdown on in vivo tumor growth. The lung tumorderived A549 cells were first transduced with lentivirus to express the deep red fluorescent
protein tdTomato which allows non-invasive monitoring of tumors at wavelengths where tissue
autofluorescence is low (Winnard et al., 2006). A549tdTomato cells with transient knockdown to
one-third of wildtype Lamin-A levels were then injected into the flanks of immuno-deficient
NSG mice, and similar numbers of control cells were injected into the contralateral sites (Fig. 45B) with 10-fold range in day-0 xenograft intensity (data not shown). Compared to untreated and
scrambled siRNA-treated control cells, tumors with partial LMNA knockdown cells grew more
rapidly (Fig. 4-5C). Importantly, the rates at which tumors doubled in normalized size were
significantly higher within the first week (up to 3-fold) for knockdown tumors compared to
controls (Fig. 4-5C inset), but the growth rates become similar, consistent with recovery from the
transient knockdown (Fig. 4-4B, S4-7).

The results provide a clear measure of the tumor

propagation advantage for what in vitro studies show are more flexible nuclei.
Day-10 after cell injection, LMNA knockdown tumors remained significantly larger than
controls. However, the difference was due only to the initial difference in growth rates because
calculated doubling rates became similar between knockdown and control tumors after about one
week. The timescale for recovery of LMNA expression after transient knockdown in vitro (Fig.
S4-7A) is similar to the timescale here for the loss of difference in tumor growth rates (Fig. 4-5C
inset), and Western blotting of late tumors indeed confirms human-LMNA expression similar to
control levels (Fig. 4-5D inset). A transient knockdown thus produced a transient bulk tumor
response, consistent with expectations.
Tumor cryo-sections were fixed and immunostained for human-LMNA and not only
revealed a general co-localization of positively stained nuclei with tdTomato fluorescence but
also showed a range of A549 nuclear shapes (Fig. 4-5D). Nuclei in the periphery of these dense
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tissues appeared more elongated in comparison to nuclei in the tumor core within the same slice,
consistent with in vitro observations of plastically elongated nuclei after migration through micropores (Fig. 4-2, 4-3A). Nuclear circularity was quantified and found to be statistically smaller at
the periphery for knockdown nuclei relative to the tumor cores of both control and knockdown
tumors (p < 0.01); control nuclei had an intermediate circularity, which perhaps indicates the
slower growth (Fig. 4-5E). A mean circularity of about 0.82-0.83 for knockdown and control
nuclei in the core compares well with the in vitro results of 0.83-0.84 for wildtype nuclei on the
top of the micro-filter, and knockdown nuclei in the tumor periphery showed a decrease (Circ ≈ 0.04) similar to that seen in vitro (Fig. 4-2C).

4-3. Discussion
A cell and its nucleus contort and displace in diverse 3D-migration processes of development and
regeneration as well as diseases such as cancer (Beadle et al., 2008; Pajerowski et al., 2007).
Lamin-A varies more widely than Lamin-B’s in health and disease (eg. Fig. 4-1B), and
surprisingly the migratory cells here with the lowest levels of Lamin-A (U251 glioblastoma cells)
show that moderate decreases in Lamin-A produce the greatest increase in 3D-migration (Fig. 41C inset). A549’s express an intermediate level of Lamin-A:B, and moderate knockdown has an
intermediate effect on their 3D-migration. Importantly, 2D-migration was unaffected for any cell
type, and at least for the A549 cells migration was also unaffected through 8 m pores that
require much less distortion of the nucleus (i.e. (3/8)2). Past work had demonstrated a dependence
of 3D- but not 2D- migration on cytoskeletal contractility with inhibition of myosin-II
compromising migration of U251 cells through 3 m pores but not through 8 m pores or on
surfaces (Beadle et al., 2008).

Very similar effects of myosin-II inhibition were also
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demonstrated here with A549 cells with Lamin-A knockdown or not (Fig. S4-8), which indicates
that cytoskeletal forces actively push and pull the nucleus – whether wildtype or lamina softened
– through a constraining pore.

Key roles for the Lamins in 3D-migration are perhaps

understandable intuitively, but scaling concepts from polymer physics help clarify the Lamin-A:B
dependence as appears relevant to both biphasic motility with migration-coupled apoptosis and in
vivo tumor growth.

4-3-1. Lamina polymer physics and distinct mechanical roles for Lamin isoforms
Previous fluorescence correlation spectroscopy (FCS) studies of GFP-Lamin fusion constructs
had indicated that Lamin-A is mobile whereas Lamin-B’s are relatively immobile (Shimi et al.,
2008). Such findings are consistent with the basic results here that Lamin-A contributes as a
viscous fluid to nuclear mechanics whereas Lamin-B contributes more as an elastic solid.
However, FCS measurements had not suggested any dependence of mobility on Lamin-A
concentration, whereas the nuclear response time correlation in Eq.2 here reveals a very strong
power law scaling (exponent of 2.5) for the apparent viscosity contributed by Lamin-A.
Importantly, the correlation (Fig. 4-1C) was obtained across multiple cell types that show some
variation in Lamin-B, and it was also obtained with Lamin-A overexpressing A549 cells with
constant Lamin-B. As mentioned, the data range spans viscosities as different as water and
honey.
The response time  for a viscoelastic system such as that schematized here (Fig. 4-2C
inset) provides a measure of the time required for the energy stored upon rapid stretching of the
elastic element to be dissipated by the viscous element. A response time for a typical oil is nanoseconds, whereas polymer melts have response times typically in the range of seconds to minutes
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(Barnes 2000). In the present context, a rapid response time is expected of the oily hydrophobic
core of the lipid bilayers that make up the nuclear envelope, whereas the dense network of
interacting Lamins are rightly considered to be high molecular weight polymers that respond
more slowly. Indeed, with high polymer concentration c in solution: viscosity ~ c3.7 (Rubinstein
and Colby, 2003). On the other hand, specific interactions of Lamin-A with Lamin-B (Schirmer
and Gerace, 2004) provide a likely basis for the weak power law increase in the effective
elasticity of the network with Lamin-A: E(t) ~ c0.5 (Fig. S4-6D). These scaling results from
simple polymer physics considerations thus suggest (viscosity/elasticity) ~ c3.2, which is
remarkably close to the ~ c2.5 results obtained here for the Lamin-A:B ratio (Eq.2). Lamin-A thus
contributes to nuclear mechanics as a highly concentrated, high molecular weight polymer that
flows slowly and irreversibly like a plastic when stressed. This explains why the high Lamin-A:B
ratio of MSCs produces the most elongated, extruded nuclei after hours-long migration through
small pores.
Lamina polymer physics can also help explain the most fundamental observation here
that moderate changes in Lamin-A have the greatest effect on cells with the lowest levels of
Lamin-A. The nucleus is the rate-limiting factor in migration through small micro-pores, and so
one can consider an Arrhenius-type model in which the rate k of a nucleus crossing the transwell
filter is slowed exponentially by the work required G by the cell to deform its nucleus: k = ko
exp(-b G) with b as a constant. Importantly, higher Lamin-A:B gives a stiffer, more viscous
nucleus (Fig. 4-3B, C, S4-5) that requires more work (G) to deform. For simplicity, we assume
a dependence of G on [Lamin-A:B] that is close to the geometric mean of the effective elasticity
E(t) and the apparent viscosity of the nucleus, which gives the linear approximation: G ~
[Lamin-A:B]. The ‘3D-migration sensitivity to Lamin-A’ defined in Fig.1C-inset is simply the
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derivative of the rate, ∂k /∂G, which is again an exponential. The prediction is thus that 3Dmigration sensitivity to Lamin-A:
m3D-sens ~ exp( - b [Lamin-A:B] ).

Eq. 3

Fig. 4-2C illustrates the predicted exponential decay.

For similar reasons, the change in

circularity of the nucleus (Circ) is also expected to depend exponentially on Lamin-A:B as shown
(Fig. 4-2C, inset).

4-3-2. An optimal lamina for 3D-migration: low lamins limit survival under stress but high
lamins immobilize cells
Stiffer materials generally withstand more stress before they break: they are stronger. Since
wildtype cells generate sufficient stress in migration through small pores to apoptose and die
(~12%; Fig. 4-4A, S4-4D), it is not surprising that Lamin-A knockdown (Fig. S4-6D) which
softens nuclei (Fig. 4-2B,C) leads to an increasing proportion of both apoptotic cells and total cell
loss (up to ~3-4 fold). The relevant molecular stresses were hinted at in proteomics analyses,
which showed that although moderate knockdown of Lamin-A perturbs the proteome to a
minimal extent (Fig. 4-1D), deep knockdown causes many major changes (Fig. 4-4B). The Btype Lamins change minimally as expected, and detected integrins increase about 2-fold which
suggests that adhesion is adequate.

The range of expression changes (see Supplemental

Discussion) and the fact that embryonic stem cells also have very low Lamin-A and are very soft
nuclei prompted an examination of at least a couple of core transcription factors, with both Oct-4
and Sox-2 appearing to increase about 2-fold after deep knockdown of Lamin-A (Fig. S4-9).
However, the protein that is most obviously indicative of compromised stress resistance is
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HSP90, which was suppressed almost as much as the transient knockdown of Lamin-A (4-fold or
more). HSP’s are involved in stabilizing or refolding proteins under stress conditions that could
include the mechanical unfolding of proteins within contractile cells (Johnson et al., 2007).
HSP90 also has a role chromatin or DNA repair (Dote et al., 2006), and a failure to repair DNA
damage in 3D-migration would certainly promote apoptosis. Indeed, the HSP90 inhibitor 17AAG increased apoptosis in the cells on the top of the filter that were just beginning to crawl
through a pore, and apoptosis was even higher after Lamin-A knockdown (Fig. 4-3D). Moreover,
this drug blocked migration through the pores regardless of Lamin-A level. The efficacy of 17AAG as an anti-cancer agent in clinical trials (Goetz et al., 2005) may reflect some of these
mechanisms of stressed migration.
For the xenografts, an initial proteomic analysis that distinguishes between proteins of
human and mouse origin (Fig. S4-10, Table S4-2), indicated aberrant expression of the stress
pathway proteins HSP90, STIP1 and AIFM1. These proteins all showed increased expression at
28 days in tumors generated after moderate Lamin-A knockdown compared to controls, although
by this time point the transient knockdown had recovered (Fig. 4-5D inset) and slightly exceeded
wildtype levels (Fig. 4-4B, Table S4-2). Apoptotic cell numbers in tumors could be low (Fig. 45A, right) for these reasons, but it is also likely that dead cells were rapidly cleared by tumorassociated macrophages.
Poor survival with low lamins and susceptibility to stress is likely to dominate the
advantage in 3D-migration of a low Lamin-A nucleus which is easier to push or pull through a
narrow constraint. PMNs (polymorphonuclear leukocytes) provide another important example of
a cell type with very low lamins, a highly flexible nucleus, and an ability to invade any tissue
during an infection, but these cells apoptose in days (Olins et al., 2001). In the opposite extreme,
a nucleus that is simply too stiff for a given cell (with its characteristic cytoskeleton) to push or
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pull the nucleus through a small opening will simply anchor the cell in place, as seen with LaminA overexpression in A549 cells here (Fig. 4-1C). Nonetheless, the large decrease in net migration
from moderate to deep knockdown of Lamin-A (Fig. 4-1C) probably reflects additional defects
here, especially in the cytoskeleton since inhibition of myosin-II also significantly impedes 3Dmigration regardless of knockdown (Fig. S4-8). Nesprin-2 is substantially lower in Lamin-A
knockdown (Fig. 4-4B,C), and although direct knockdown of this linker between cytoskeleton
and nucleus impedes 2D-migration (Luxton et al., 2010), there are no reports yet linking Nesprin2 to apoptosis. With Lamin-A knockdown tumors, -actinin-4 is also low (Table S4-2 bottom),
and knockdown of -actinin-4 suppresses invasiveness of oral squamous carcinoma cells
(Yamada et al., 2010).

From these basic biophysical considerations of nucleus and the

interconnected cytoskeleton emerges an expectation for biphasic 3D-migration versus Lamin-A
levels, with implications for lamin variations in differentiation as well as disease.
Malignancies associated with increased levels of Lamin-A (Foster et al., 2010; Tilli et al.,
2003) could therefore reflect the pro-survival function of Lamin-A in stressful 3D-migration of
these cells. Xenograft studies here indeed show that Lamin-A levels can vary within a tumor
(Fig. 4-5A), and Lamin-A levels can also impact the rates of tumor growth (Fig. 4-5C). The
A549 cells studied here have more Lamin-A than Lamin-B (Fig. 4-1B), but there is also sufficient
variation within a wildtype or knockdown cell population to produce more rapid 3-D migration of
low Lamin-A cells, thus causing segregation in vitro (Fig. 4-3A). In vivo studies here likewise
showed Lamin-A levels are lower in the growing periphery of the tumor than in the core (Fig. 45A), correlating with nuclear shape in vivo (Fig. 4-5D,E) despite the much more complex
microenvironments than that used in vitro to reach similar conclusions (Fig. 4-3A). These latter
findings seem especially pertinent to the low Lamin-A levels that have been associated with the
recurrence of colon cancers (Belt et al., 2011). Explanations for both increases and decreases in
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Lamin-A in processes such as tumorigenesis thus have a basis in the biphasic motility response
(Fig. 4-1C).

Lastly, nuclear Lamins are of great interest not only in the context of disease, but also in aging,
development and differentiation of stem cells (Akter et al., 2009; Frock et al., 2006; Scaffidi and
Misteli, 2006). Specific or direct roles of Lamin isoforms seem controversial, with recent LaminB knockouts appearing surprisingly viable until birth when apoptosis in migration through the
brain is apparent (Kim et al., 2011). Since Lamin-A is low in the brain and does not compensate,
the fundamental insight here into lamina stabilization of the nucleus in 3D-migration explains the
phenotype. Further understanding of the roles for both isoforms in cell migration speed and cell
viability could be useful in fine-tuning cell behaviors in vivo, similar to PMNs, thereby
contributing to cancer diagnostics as well as cell therapy with MSCs and perhaps other stem cells.

4-4. Conclusions
Biphasic dependence of cell migration on Lamin-A expression suggests complicated and
contradictory roles of nuclear stiffness in cell behaviors. The results seem to imply the optimal
nuclear stiffness for cell migration in dense tissue, whereas excessively stiff nucleus physically
impedes migration while cells with too soft nuclei suffer from migration-induced mechanical
stress and resulting apoptosis. This result may explain surprisingly short life span of PMNs after
transmigrating into tissue, for these highly motile cells are known to possess significantly low
lamins and are considered to be affected by migration-associated mechanical stress in tissues. Ex
vivo analysis of growing tumors indicated slightly higher cell death frequency compared to base
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line level determined with cell populations on the upper side of transwell filters. Smaller number
of apoptotic cell in tumor in comparison with those found on the bottom side of transwell
membrane could be explained by heterogeneous pore size of ECM mechwork since there should
be a threshold for induction of migration-induced mechanical stress between 3 and 8 m pore
size, or rapid clearance of dead cells by tumor associated macrophages. Detailed mechanism of
migration-induced cell death in constraining environment is still under investigation, but initial
proteomic analyses indicated aberrant expression of stress-related proteins such as HSP90, STIP1
and AIFM1. Those stress-related proteins showed increased expression in siLMNA+ tumors after
28 days of in vivo growth and may explain suppressed elevation of growth rate observed in our in
vivo experiments. The presented results here will help us understand the important roles of
nuclear lamina serving at the same time as an obstacle against migration and as a resistance
against mechanical stress to help completion of migrations.
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4-5. Supplemental Discussion
Broad Proteomic Influences of Deep Lamin-A Knockdown
Among various changes, nesprin-2 down-regulation could be a part of the reason for suppressed
migration. Nesprin-2 is linking nuclear lamina and cytoskeleton to coordinate nucleus and
centrosome positioning, and previous study showed depletion of Nesprin-2 resulted in decreased
2D migration in fibroblasts (Luxton et al., 2010). The increase of expressions in integrin 5 and
1, which form heterodimer to bind to fibronectin, could explain better migration of deep
knockdown cells through fibronectin-coated filter compared to non-coating condition, matching
the recent result where integrin 5-downregulated lung carcinoma cells showed suppressed
migration and tumor propagation (Roman et al., 2010). Although interaction between integrins
51 and fibronectin is known to play important roles in various processes including migration
and proliferation, one should be reminded that correlation of integrin expression level to the
extent of those cell behaviors is still controversial due to contradictory results of previous works.
Although contradictory to the hypothesis on suppressed migration with deep knockdown, the
down-regulation of -catenin is worth noting since reduced -catenin is one of the markers of
epithelial-mesenchymal transition (EMT) (Yang et al., 2004), in which carcinoma cells acquire
mesenchymal cell-like properties and therefore become more migratory. Together with upregulation of integrin 1, which was previously shown to make migrating epithelial cells favor
the mesenchymal-like motility (Friedl et al., 1997), A549 cells with significantly low lamin-A
expression (particularly with deep knockdown ones) acquired more migratory mesenchymal-like
phenotype, but with cytoskeltal defects that need to be elucidated, many of the cells failed to
complete the migration. Those successfully left the monolayer on upper side of the transwell filter
suffered from apoptosis caused by migration-associated mechanical stress. Proteome of lamin-A
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deep knockdown A549 cells should need more detailed analysis to determine the mechanism of
migration defect in those cells.
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4-6. Materials and Methods
Cells and mice
Human lung carcinoma A549 and mesenchymal stem cells were purchased from ATCC and
Lonza, respectively. Glioblastoma multiforme U251 cells were kind gift from Dr. Jay Dorsey.
Cells were cultured in accordance with the supplier’s instructions. Lentiviral particles
encapsulating tdTomato-encoding plasmid were a kind gift from Dr. Carmine Carpenito. 105
A549 cells were incubated with lentivirus with MOI of approximately 7.5 for 24 hours. Cells
were expanded following selection of tdTomato-positive cells, using a cloning cylinder (Bel-Art
Products). Non-obese diabetic/severe combined immunodeficient (NOD/SCID) mice with null
expression of interleukin-2 receptor gamma chain (NSG mice) were produced by the Stem Cell
and Xenograft Core Facility at the University of Pennsylvania, using breeders obtained from the
Jackson Laboratory (Bar Harbor). All animal experiments were planned and performed according
to IACUC protocols.

Lamin-A knockdown and characterization
All siRNAs used in this study were purchased from Dharmacon. A549 cells were passaged 24
hours

prior

to

transfection. A

GGUGGUGACGAUCUGGGCU-3’

complex of siRNA
and

(30
siLMNA

nM;

siLMNA
2,

1,

5’5’-

AACUGGACUUCCAGAAGAACAUC-3’ (Elbashir et al., 2001)) and 1 g/mL Lipofectamine
2000 was prepared according to the manufacturer’s instructions and incubated for 24 hrs per dose
for up to three doses (in high glucose DMEM with 10% FBS for A549 and U251 and in low
glucose DMEM with 10% FBS for MSC). Single 30 nM dose is denoted in this study as
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“siLMNA+,” and three daily doses of 30 nM to achieve deep knockdown as “siLMNA++.”
Results were compared with those using the same dose of scrambled siRNA. For untreated
controls, an equal volume of opti-MEM (Invitrogen) was used. Knockdown efficiency was
determined by Western blot following standard methods. Antibodies against Lamin-A (sc-7292)
and -Actin (sc-47778) were obtained from Santa Cruz Biotechnology (Santa Cruz). The effect of
Lamin knockdown on cell proliferation was measured with thiazolyl blue tetrazolium (Sigma),
following the standard MTT assay protocol.

2D and 3D migration assays
Stained cells were observed by epifluorescence microscope Olympus IX71 for all the
experiments. 2D (wound healing assay): 105 A549 cells were seeded on 24-well plates. After 24
hrs, cells were treated with 1 dose of 30 nM siRNA (Lamin knockdown or scrambled) as
described above. After 5 days, a scratch was made in the monolayer of cells and the width of the
scratch measured in three places at 0, 3, 6 and 9 hrs. Lamin-A expression in migrating cells was
measured by immunostaining cells at the wound frontiers. 3D (transwell migration assay):
Multiwell inserts with filters of 3 m or 8 m pore were purchased from BD Biosciences.
Fibronectin coating was achieved by incubation with 50 g/mL human fibronectin (BD
Biosciences) solution for 2 hours at 37C (Meng et al., 2009). 1105 cells were seeded in serumfree medium in the upper well and DMEM supplemented with 20 % FBS was added to the
bottom well to establish a nutrient gradient across the filter. For drug treatment during migration
assay, 2 M of (-)-blebbistatin or 60 nM of 17-AAG (LC Laboratories) was added to both upper
and bottom wells. In case of 17-AAG, cells were pre-treated with the drug for 24 hours before
starting the assay. After incubation at 37C with 5% CO2 (24 hours for A549 and MSC, and 6
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hours for U251 cells), cells were fixed with 3.7% formaldehyde (Fisher Scientific). Based on the
necessity, cells were stained for: DNA with Hoechst 33342; Lamin-A (sc-7292); Lamin B (1
antibody sc-6217 from Santa Cruz Biotechnology); cleaved caspase-3 (1 antibody from Cell
Signaling). After staining, filters were cut out from the insert, and mounted on cover slips using
Fluoro-Gel (Electron Microscopy Sciences). 20x and 40x objectives were used for nucleus
counting and caspase-3 observation, respectively.

Micropipette aspiration
Prior to aspiration experiment, cells were treated with 0.2 g/ml of Latrunculin A (Sigma) for 1
hour at 37C, detached with trypsin/EDTA, centrifuged and resuspended in aspiration buffer (135
mM NaCl, 5mM KCl, 5 mM HEPES, 1.8 mM CaCl2, 2 mM MgCl2, 2% BSA, 1:3000 propidium
iodide (Molecular Probes)). Cell nuclei were stained with Hoechst 33342 (Molecular Probes).
Nuclear compliance was measured as membrane extension under negative pressure inside a
micropipette needle. Epifluorescence imaging was done with a Nikon TE300 inverted microscope
coupled with a digital CCD camera (Roper Scientific), using a 60x oil immersion objective.
Harvested A549 tumor tissues, pre-treated with collagenase (Sigma) or blebbistatin (Calbiochem)
if necessary, were soaked in Ham’s F-12 media (Invitrogen) during aspiration, visualized with
20x objective.

Quantitative proteomic profiling
Cell or tissue lysates were run on SDS-PAGE and the 60 – 80 kDa molecular weight range
excised from the gel. Samples were prepared, run on LC-MS/MS (LTQ-Orbitrap, Thermo Fisher
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Scientific) and analyzed by a combination of Elucidator (Rosetta Biosoftware) and in-house
software, as described previously (Shin et al., 2011).

Establishment of A549 tumors in mice
tdTomato-expressing A549 cells were detached with trypsin, washed with PBS, and suspended in
PBS containing 25% Matrigel (BD biosciences) at a concentration of 2107 cells/mL. Each
mouse received two injections of one million cells at two flank sites, siLMNA-treated cells on
one side and control cells on the other. Tumor progression was evaluated by tdTomato
fluorescence emission from tumors using an IVIS Spectrum Imaging System (Caliper Life
Sciences), imaged with 535/640 nm excitation/emission. Image analysis was done with Living
Image Software (Caliper Life Sciences). Tumors were grown for 28 days before harvesting.
Tumor slices (10 m thick) were fixed with 3.7% formaldehyde, permeabilized with 0.25%
Triton X-100, and blocked with BSA. Tissue was stained for human Lamin A and nuclei were
counterstained with Hoechst 33342, and then observed with 40x objective. Tissue remaining after
cryo-sectioning was lysed in RIPA buffer and prepared for MS and Western blotting following
standard protocol found elsewhere. For tumor tissue decellularization, tissue was first soaked in
1% SDS (BIO-RAD) solution and incubated at r.t. overnight with one solution exchange. Then
tissue was washed with 1% Triton X-100 solution for 30 min at r.t., followed by equilibration
with PBS.

Intracellular staining of Lamins in tumor-derived A549 cells
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After harvested, A549 tumors are separated into core and peripheral portions, further cut into
smaller pieces of ~few mm3. Tumor tissue pieces were incubated in F-12 growth medium
containing 0.2 mg/mL collagenase (Sigma) at 37C with 5% CO2 for 0.5-1 hour. Isolated cells
were collected and fixed/permeablized using flow cytometry fixation/permeabilization buffer
(R&D systems), following manufacturer’s instructions. For cultured A549 cells, fixation and
permeabilization was done using 3.7% formaldehyde and 0.25% Triton X-100 (MP Biomedicals)
in PBS, respectively. Cells were stained for Lamin-A and B with Alexa-488 and -647 conjugated
secondary antibodies (all samples were treated with antibodies of fixed concentration ratio),
respectively, and intensities were measured with FACSCalibur (BD Biosciences). Apoptotic cells
were detected based on positive signal for both Lamin-A (stained with Alexa 488 secondary
antibody) and cleaved capsease-3 (Alexa 647) by microscopic observation with 20X objective
lens.
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Figure 4-1. 3D-migration is sensitive to Lamin-A levels even in the absence of major
proteomic changes. (A) Hypothesis for the impact of Lamin-A levels on migrating cells. While
moderate expression permits migration, cells with low levels cannot withstand the stress and high
levels impede migration. Inset: brightfield image of detergent-decellularized tumor, where dark
regions corresponding to pores. (B) Wildtype 3D-migration through transwell filter (i, schematic)
and lamina parameters (ii, iii) for: A549 (blue), MSC (green) and U251 (red) cells. (n  3;
SEM; *p ≤ 0.05).

Calculations of Lamin isoform levels are in Fig. S3C. (C) Lamin-A

dependence of net cell migration to the Bottom of the filter (main plot, n  3; SEM).
Normalization is done to scrambled siRNA-treated cells, with Lamin-A level determined by
western blot. Filters were pre-coated with fibronectin coated unless indicated. Circles: siLMNA86

treated cells. Squares: untreated. Triangle and diamond: A549 cells transduced with GFP-LaminA with low and high levels, respectively. Inset plot, migration results rescaled to Lamin-(A+B)
levels (also see Fig. S3C) and net migration relative to wildtype A549 cells (Fig. 1B left
bargraph). The indicated slopes represent the 3D-migration sensitivity to a moderate Lamin-A
change in each cell type. (D) Negligible disruption to the A549 proteome after 50% knockdown
of Lamin-A is evident in a narrow, log-normal distribution relative to wildtype cells.
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Figure 4-2. Lamin-A plasticizes nuclei, with persistent shape changes correlating with both
3D-migration sensitivity to Lamin-A and also with the Lamin-A:B ratio. (A) Images of
nuclei on the micro-pore filters stained for either Lamin-B or DNA (Hoechst 33342). Arrowheads
indicate a nucleus in a pore, either partially or completely. Knockdown with siLMNA was >95%
(3 m) or 60% (8 m). Inset image of siLMNA cell with nucleus coming out of the bottom of 3
m pore and showing segregation of lamin-A from lamin-B as clarified by line intensity profiles.
Inset bargraph: net migration ratio with 8 m pore filters shows no effects of Lamin-A
knockdown for both fibronectin-coated and uncoated filters (±FN). (B) Exponential correlation
between 3D-migration sensitivity to Lamin-A levels (values in Fig. 1C inset) and the difference
in circularity of wildtype nuclei on the top versus the bottom of 3 m filters (n > 60; ±SEM).
Inset images: nuclear shapes on top and bottom of filters. The three datapoints fit well with two
parameters:  = 14,  = 23 (R2 > 0.99). (C) Exponential decay of migration sensitivity with
Lamin-A:B ratio. Inset plot shows negative correlation of migration-induced nuclear circularity
change with Lamin-A:B ratio. All data points fitted to exponential decay equation. Exponential fit
is approximated from panel-(B), but with fit parameters: a (≈ ) = 33, b = -1, c (≈ 0) = 0.8 (R2 >
0.99). Inset scheme illustrates distinct physical roles of Lamin-A and Lamin-B as influencing,
respectively, nuclear viscosity (dash pot) and nuclear elasticity (spring).
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Figure 4-3. Variations in Lamin-A lead to cell sorting in 3D-migration, consistent with
Lamin-A:B regulation of nuclear response time. (A) Nuclei on the bottom of the filters
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compared to the top show a lower absolute ratio of Lamin-A:B and also lower nuclear circularity
(n  50; ±SEM), consistent with segregation in 3D-migration based on softness of the nucleus.
The immunofluorescence results for intensity of Lamin-A (shown) and Lamin-B were re-scaled
to the absolute ratio of 2.3 (Fig. 1B-ii). Red circle, triangle and square symbols correspond to
high, medium and low doses of siLMNA, respectively. Results are fit segmentally to
exponentials: y = 0.81 exp(0.015 x) (top, R2 = 0.86) and y = 0.66 exp(0.083 x) (bottom, R2 =
0.78). (B) Fluorescent microscope images of aspirated nuclei stained with Hoechst 33342 under
high (~2.1 kPa) and low (~0.5 kPa) pressure. Plot shows nuclear membrane extension under
different aspiration pressures after 5 min (n = 4; ±SEM; *p < 0.01). See Methods for cell
treatments. Controls are both non-treated and scrambled siRNA-treated cells fitted to single line.
Scale bar is 5 m. (C) Power law dependence of nuclear response time, , on Lamin-A:B for
individual Lamin-A overexpressing cells (top) and the three cell lines including knockdown cells
(bottom, n  4; ±SEM). Aspirated lengths were rescaled by pipette diameter and pressure (to J in
Fig. S6A), and the various response times were obtained for 2.5 kPa-1 (= J for upper plot) and 7
kPa-1 (= J for lower plot).  (= 2.5) is the fitted power low exponent.
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Figure 4-4. 3D-migration enhances apoptosis, and ablation of Lamin-A compromises
HSP90-dependent, stress protection. (A) Images show an A549 cell that is still partially in a 3
m pore (left panel) and staining positive for the apoptosis marker cleaved caspase-3 (green, right
panel; blue, DNA Hoechst 33342). Scale bar is 10 m. The plot shows the increased frequency of
apoptotic A549 cells on the bottom of 3 m pore-filter after Lamin-A knockdown, as measured
by Western blots (inset). Cells on the top show a negligible dependence of apoptosis on Lamin-A.
(n = 10; ±SEM). Filled and open symbols represent fibronectin-coated and uncoated filters,
respectively. (B) Changes in the expression levels of proteins of interest, detected by quantitative
mass spectrometry, following transient Lamin-A knockdown and recovery over 14 days (n = 3;
±SEM). (C) Changes in Lamin-A, Lamin-B, Nesprin-2 and HSP90 were confirmed by Western
blot for wild-type and 5-day post-knockdown cells. (D) Upper plot: Apoptosis in cells on top side
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of 3 m pore filter increased with 17-AAG treatment (filled bars, 60 nM) in comparison with
DMSO control (open bars). Apoptosis was enhanced by Lamin-A knockdown. Lower plot: 17AAG-treated cells were not found on the bottom of the filters, indicating a complete failure to
migrate through 3 m pores when HSP90 is inhibited. (n = 10; ±SEM).
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Figure 4-5. Cells in the tumor periphery show low Lamin-A:B in more deformed nuclei,
consistent with enhanced tumor growth after moderate knockdown of Lamin-A. (A) (Left
scheme) Intracellular immunostaining of lamins in A549 cells isolated from core and peripheral
portions of wild-type tumors followed by flow cytometry measurements. (Center bargraph) A549
cells were distinguished from mouse cells based on positive staining with human specific LaminA primary antibody. Lamin-A:B intensity ratio showed a statistically significant difference
between core and periphery-derived cells (n = 6; ±SEM). (Right bargraph) Frequency of cleaved
caspase-3 positive tumor-derived A549 cells were obtained by imaging cells positively stained for
both human Lamin-A and cleaved caspase-3 (n  46; ±SEM). (B) In situ imaging of A549 cells
that were stably expressing tdTomato and xenografted into subcutaneous flank sites of NSG mice.
Each mouse received siLMNA-treated cells in one side and control cells, untreated (NT) or
scrambled-RNA (Scr), on the opposite side. Lamin-A knockdown was confirmed by western blot
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analysis. (C) Tumor propagation measured by tdTomato signal from tumors up to 17 days postengraftment, with double exponential fits of growth (n = 10 for siLMNA+, n = 5 for NT and Scr;
±SEM). Inset: Growth rates as reciprocal doubling times calculated from consecutive time
points (n = 10; ±SEM; p < 0.05). (D) Representative fluorescence images of cells in core and
periphery regions of tumor tissue sections, stained for DNA (Hoechst 33342, blue) and anti(human Lamin-A) (green) with red fluorescence from tdTomato. Inset: Westerns of tumors with
anti-(human Lamin-A) and constant total protein show Lamin-A,C has recovered after moderate
knockdown. (E) Circularity analysis of A549 nuclei in control or Lamin-A knockdown tumor
tissue slices (n  25; ±SEM). Cell populations were divided into core and periphery as in (A). (n
= 4 tumors).
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Figure S4-1. Matrix-dictated Stiffness of Tumor Tissue (A) In addition to untreated condition,
tumors were either treated with collagenase (ECM degradation or softening) or blebbistatin (cell
softening) with different concentration and treatment time (n  5; ±SEM). Stars represent
statistically significant difference (p < 0.05) from untreated tissue. Elastic stiffness was calculated
according to previous work (Dahl et al., 2005). (B) Representative images of aspirated tumor
tissues with (right) or without (left) 0.1 mg/mL collagenase treatment for 10 min. Scale bar is 20
m. (C) Averaged compliance of aspirated tumor tissues under constant pressure (19.8  0.8 kPa
for untreated tissues and 19.4  0.6 kPa for collagen treated tissues), measured over 30 sec of
aspiration (n  5; ±SEM).
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Figure S4-2. Moderate changes in Lamin-A do not affect 2D migration, but 2D migration
always correlates positively with 3D migration (A) Wound scratch healing assay for Lamin-A
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knockdown (open circles) as well as untreated (open squares) and scrambled siRNA-treated
(filled squares) A549, MSC and U251 cells (n > 3; ±SEM). (B) Relative migration efficacy of
siLMNA+ and control siRNA-treated cells is plotted against relative migration velocity on
surface measured in Fig. S2A for A549, MSC and U251. Control siRNA-treated A549 is set as 1
for both axes.
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Figure S4-3. Cells with distinct origins and Lamin profiles demonstrate varied 3D migration
sensitivity to Lamin-A change (A) In vitro immunofluorescence for Lamin isoforms A and B.
Error bars represent standard deviation (n > 120; ±SEM). (B) Western blots of Lamin isoforms
for A549, MSC and U251. (C) Table summarizing Lamin-A:B, B, A and A+B values for A549,
MSC and U251 cells. Calculations used for obtaining values appearing in inset bar graphs of Fig.
1B are shown below. (D) x- and y-axes are rescaled from Fig. 1C main plot values to Lamin-A:B
and relative migration capacity of control cells (n  10; SEM). Values in the plot are gradient of
migration against Lamin-A:B change by ~50% Lamin-A knockdown.
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Figure S4-4. siLMNA’s with distinct targets consistently increase 3D migration without
affecting viability in 2D or in migration thru large pores, but cell numbers are reduced with
small pores and with knockdown (A) Recovery of suppressed migration capacity in GFPLamin-A overexpressing A549 cells by partial Lamin A knockdown (n = 10; SEM; star p<
0.01). (B) Non-linear dose dependence of A549 migration (3 m pores) with siLMNA 2 (n = 10;
SEM; star p< 0.01). (C) Cell proliferation assay of siLMNA-treated cells, showing relative cell
viability against scrambled siRNA control on the same time points (n = 2; SEM). (D) Relative
total cell numbers on both sides of transwell filters (Number of scrambled siRNA-treated cells on
8 m-pore filter after 24 hours as 1, with the same initial number of cell seeded for all conditions)
for A549 cells treated with scrambled siRNA or different doses of siLMNA (n = 3; SEM; star
p< 0.05).
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Figure S4-5. Extent of nuclear deformation by small pore migration shows cell-type
specificity (A) Negligible influence of migration through 8 m-pore filter on nuclear circularity,
irrespective of Lamin-A knockdown (n > 160; SEM). (B) Comparison of nuclear circularity
change after migration through 3 m-pore filter for A549, MSC and U251 cells (scrambled
siRNA-treated). n > 70; SEM. (C) Representative images of nuclei of MSC and U251 cells on
top and bottom sides of transwell (3 m) filter.
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Figure S4-6. Micropipette aspiration reveals Lamin-A dependence of nuclear stiffness and
elasticity (A) A549 nuclear compliance change with time under constant pressure (~0.5 kPa) with
a power law fit for siLMNA+ and control cells (n = 4; ±SEM). (B) Nuclear Compliance of GFPLamin-A overexpressing A549 cells. (C) Nuclear compliance change with time of A549, MSC
and U251 cells under 2-3 kPa pressure (n  4; ±SEM). (D) Nuclear elastic stiffness obtained with
micropipette aspiration for GFP-Lamin-A overexpressing A549 cells (upper) and the three cell
lines (bottom, n  4; ±SEM).
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Figure S4-7. Transient Lamin-A knockdown causes little change in nuclear volume (A)
Changes in normalized Lamin-A expression (filled circles) and projected nuclear area (open
circles) after either siLMNA or scrambled siRNA treatment were monitored over 17 days (n > 50;
SEM). Inset is western blot image of A549 cells treated with either scrambled siRNA (Scr) or
siLMNA. For siLMNA treatment conditions, A549 cells were collected for western blot
measurements at different time points corresponding to the ones on the main plot. The bands
correspond to Lamin-A, Lamin-C and -Actin from top to bottom. (B and C) Subpopulation
analysis of Lamin-A knockdown cells from day 1 post-transfection. Cells divided into subgroups
based on Lamin-A expression level (B), and nuclear area vs. averaged Hoechst 33342 intensity in
small area at center of nucleus, representing nuclear height, was compared between subgroups
(C).
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Figure S4-8. Mosin II-dependent A549 migration (A) Trans-well migration assay under the
treatment with myosin II inhibitor blebbistatin. A549 cells with Lamin-A knockdown were
induced to migrate through 3 m pores in the presence of 2 M blebbistatin with no coating (left)
or fibronectin coating (right). Stars represent statistically significant difference (n  18; ±SEM;
star p< 0.05). (B) Effect of blebbistatin (2 M) treatment of 2D migration velocity of A549 cells,
either treated with siLMNA+ or control siRNA (n = 3; SEM).
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Figure S4-9. Deep Lamin-A knockdown Induces up-regulation of pluripotency markers (A)
Western blot for wild type and Lamin-A deep knockdown A549 cells at several time points
during siLMNA++ treatment. Both antibodies for oct 4 and sox 2 were purchased from Novus
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Biologicals. (B) Intensity values obtained in (A) are summarized. Intensities are normalized by
those of -Actin.
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Figure S4-10. Label-free mass spectrometry distinguishes human- and mouse-specific
proteins Venn diagrams showing sequence over lap of A549 proteins detected in vitro (left) and
human- and mouse-unique proteins detected from harvested tumors (right).
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Table S4-1. Proteome of Lamin-A moderate knockdown A549 cells Comparison of proteome
between wild-type and 50% Lamin A knockdown A549 cells. Values in heat-map represent
relative expression between knockdown and wild-type cells.
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Table S4-2. Proteomic difference between tumor vs. cultured cells (A) Mass spectrometryderived quantitation of protein expression in Scr and two siLMNA tumors relative to that of
scrambled siRNA-treated in vitro cultured cells (first three columns). The forth column represents
relative expression of the same set of proteins between Scr and average of the two siLMNA
tumors.
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Chapter 5: Conclusions

5-1. Long-circulating Nano-particles for Cancer Therapies
Based on the previous studies with flexible Filomicelles showing increased circulation
time and enhanced therapeutic efficacy against model subcutaneous tumor, the presented
study explored the possibility of the use of Filomicelles against brain tumor, which is one
of the most challenging types of cancer. Brain tumor cell, or glioblastoma multiforme,
itself shows high susceptibility against model drug used in this study, paclitaxel (TAX). It
is the poor accessibility that makes brain cancer highly difficult to cure. Strict control of
material transport across the brain vasculature (BBB) rejects intravasation of even small
molecules (< kDa) as well as macromolecules or sub-micron particles. Filomicells were
previously shown to circulate long enough to reach brain vasculature, but remained inside
the blood vessel. This observation motivated the use of radiation therapy to achieve
temporal disruption in BBB to let circulating particles sneak into the brain tumor tissue to
release the cargo drug molecules inside. Successful extension of the survival of brain
tumor-bearing mice treated with the combination therapy is encouraging, but the future
study needs to cover entire sets of controls necessary to support the current result: empty
carrier control; conventional formulation of TAX with Cremophor EL; and less
circulating polymer nano-carrier with non-worm morphologies. TAX dose dependence of
therapeutic effect will also strongly support validation of the combination therapy.
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Longer circulation time of a drug-loaded nano-particle increases the possibility of
the system to eventually reach the tumor tissue. Widely used PEG is beneficial for
avoiding the attachment of particular serum proteins, opsonins, which serves as a flag for
immune cell to recognize the particles and uptake. Many studies have shown eventual
opsonization of PEG-coated particles, which inevitably leads to the clearance form
systemic circulation and poor therapeutic effect of drug delivery system. Attachment of
CD47 or CD47-derived ‘Self’ peptide increased accumulation of model particle in
subcutaneous tumor tissue and even tumor shrinkage when TAX was loaded. The future
study should apply CD47 or ‘Self’ peptide to real drug delivery system instead of
polystyrene beads, with particular disease model rather than flank tumors. Combination
use of PEG and ‘Self’ protein/peptide may be possible to achieve next-generation
targeted therapeutics that can actively avoid both opsonization and clearance by immune
cells in case the particle eventuall get opsonized.

5-2. Nuclear Physics of Cancer Cells and Tumor Progression
Lamin-A,C expression and nuclear stiffness varies significantly among cell types with
distinct origins, recently revealing the strong correlation with surrounding tissue stiffness.
This observation in a sense leads to the reduction that nuclear Lamins have strong
influences on wide range of cell phenotypes form differentiation state to cell migration
capacity. Lamin isoform ratio nicely predicts cell migration sensitivity to Lamin-A,C
expression change and nuclear physics (i.e. viscosity vs. elasticity of nucleus as a
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viscoelastic material) with all the tested three cell lines with different origins, functions
and phenotypes. Lamin-A,C knockdown commonly reduces the obstacle for cell
migration process in all tested cell lines, but at the same time impairs protection against
mechanical stress exerted against cells migrating through physically constraining
environment. Understanding or better control of Lamin-A,C expression and cell
migration capability in particular cell is beneficial in various possible applications such as
cancer diagnosis/prognosis (deducing the reports that some cancer cells possess LaminA,C level different from surrounding healthy cells) or optimization of motility of
mesenchymal stem cells that can be used in regenerative medicine. Future study requires
further investigation into how quantitatively Lamin-A,C affects migration in individual
cell level in various cell types to achieve better prediction of cell motility in real tissues.
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